<SEC-DOCUMENT>0001213900-25-118971.txt : 20251208
<SEC-HEADER>0001213900-25-118971.hdr.sgml : 20251208
<ACCEPTANCE-DATETIME>20251208080955
ACCESSION NUMBER:		0001213900-25-118971
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251208
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251208
DATE AS OF CHANGE:		20251208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kindly MD, Inc.
		CENTRAL INDEX KEY:			0001946573
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				843829824
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42103
		FILM NUMBER:		251554707

	BUSINESS ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		(385) 388-8220

	MAIL ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0268789-8k_kindlymd.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:NAKAW="http://kindlymd.com/20251208">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_NAKAW_kindlymd.com_20251208 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20251208_20251208 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001946573 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000004" name="dei:EntityCentralIndexKey">0001946573</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="nakaw-20251208.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001946573</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-08</xbrli:startDate>
        <xbrli:endDate>2025-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001946573</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NAKAW:CommonStockParValue0.001Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-08</xbrli:startDate>
        <xbrli:endDate>2025-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001946573</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NAKAW:TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-08</xbrli:startDate>
        <xbrli:endDate>2025-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90F_edei--DocumentType_c20251208__20251208_zXTtLMpxBxhk"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br/>
PURSUANT TO SECTION 13 OR 15(d) OF<br/>
THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20251208__20251208_zyrXYKKk28jj"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 8, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20251208__20251208_zl9pgQwR8Gpk"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000011" name="dei:EntityRegistrantName">Kindly MD, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20251208__20251208_zUnUfSARbPD2"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000012" name="dei:EntityFileNumber">001-42103</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20251208__20251208_znrsbPDNsqu8"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000013" name="dei:EntityTaxIdentificationNumber">84-3829824</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission <br/>
File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br/>
 Identification Number)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20251208__20251208_z7lkepBStbdk"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000014" name="dei:EntityAddressAddressLine1">5097 South 900 East</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20251208__20251208_z7vCV6tscSOf"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000015" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressCityOrTown_c20251208__20251208_zVxjUGyxK4Mg"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000016" name="dei:EntityAddressCityOrTown">Salt Lake City</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20251208__20251208_zXgQbXJA2q0j"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000017" name="dei:EntityAddressStateOrProvince">UT</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressPostalZipCode_c20251208__20251208_zQkkPjw1KIRe"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000018" name="dei:EntityAddressPostalZipCode">84117</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_909_edei--CityAreaCode_c20251208__20251208_zkGEXOvKRlGj"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000019" name="dei:CityAreaCode">385</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20251208__20251208_zzsuwCz3La18"><ix:nonNumeric contextRef="AsOf2025-12-08" id="Fact000020" name="dei:LocalPhoneNumber">388-8220</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">N/A</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_900_edei--WrittenCommunications_c20251208__20251208_zti0DxFclZN3"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20251208__20251208_zXoFDoiOHC13"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20251208__20251208_z5vb4P3mFsE6"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20251208__20251208_z8igrFdOR8rd"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Each Exchange on Which Registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20251208__20251208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001Member_z76GnMIBarQ1"><ix:nonNumeric contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.001</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20251208__20251208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001Member_zZxR8TupI2Mk"><ix:nonNumeric contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member" id="Fact000026" name="dei:TradingSymbol">NAKA</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_906_edei--SecurityExchangeName_c20251208__20251208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.001Member_zvQW5L59Y3uj"><ix:nonNumeric contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20251208__20251208__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_zLxw3MwGOwR7"><ix:nonNumeric contextRef="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" id="Fact000028" name="dei:Security12bTitle">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20251208__20251208__us-gaap--StatementClassOfStockAxis__custom--TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_z11hJ971YqS7"><ix:nonNumeric contextRef="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" id="Fact000029" name="dei:TradingSymbol">NAKAW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTC Pink Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20251208__20251208_zrELh3Sirloj"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleantrue" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_edei--EntityExTransitionPeriod_c20251208__20251208_zYcpYno9Onte"><ix:nonNumeric contextRef="AsOf2025-12-08" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Appointment of Chief Financial Officer</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 8, 2025, the Board of Directors (the
&#8220;<b>Board</b>&#8221;) of Kindly MD, Inc., a Utah corporation (the &#8220;<b>Company</b>&#8221;) appointed Teresa Gendron, age 56,
as&#160;Chief Financial Officer&#160;of the Company, effective December 8, 2025 (the &#8220;<b>Effective Date</b>&#8221;). Ms. Gendron
will also serve as the Company&#8217;s Treasurer. Ms. Gendron will replace Jared Barrera, who will step down from the role of&#160;Chief
Financial Officer and into a role as Senior Vice President of Finance, effective immediately. Mr. Barrera&#8217;s employment agreement,
initially dated September 1, 2023, will continue and there will be no changes to the terms of the employment, other than his role.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to her appointment, Ms. Gendron served as
Chief Financial Officer of Markel Group Inc., a publicly traded insurance and investments company listed on the New York Stock Exchange,
from March 2023 to December 2023, and as Chief Financial Officer of Jefferies Financial Group Inc., a publicly traded financial services
company listed on the New York Stock Exchange, from September 2014 to March 2023. Since July 2021, she has served as a director and Audit
Committee member of Hillman Solutions Corp., a publicly traded company. Ms. Gendron holds a bachelor&#8217;s degree in accounting from
the University of Virginia, and an MBA degree from Georgetown University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no arrangements or understandings between
Ms. Gendron and any other person pursuant to which Ms. Gendron was appointed to serve as the&#160;Chief Financial Officer&#160;of the
Company. There are no family relationships between Ms. Gendron and any of the Company&#8217;s directors or executive officers. Ms. Gendron
has no direct or indirect material interest in any existing or currently proposed transaction that would require disclosure under Item&#160;404(a)&#160;of&#160;Regulation
S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with her appointment as Chief Financial
Officer, the Company entered into an employment agreement with Ms. Gendron (the &#8220;<b>CFO Employment Agreement</b>&#8221;) dated December
8, 2025. Under the terms of the CFO Employment Agreement, Ms. Gendron will receive an annual base salary of $450,000, and will be eligible
for annual incentive compensation with a target of up to 150% of the base salary, subject to performance metrics established by the Board.
Ms. Gendron will also be eligible to receive an initial grant of performance-based restricted stock units valued at $1,000,000, which
will vest over a four-year period from the Effective Date, subject to performance metrics established by the Board and other customary
terms. The agreement contains customary confidentiality, non-compete, non-solicitation, and intellectual property provisions, and may
be terminated by either party in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Gendron will also be entitled to participate
in the Company&#8217;s employee benefit plans made available to similarly situated employees, as well as directors&#8217; and officers&#8217;
insurance and indemnification consistent with other executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CFO Employment Agreement provides that Ms.
Gendron&#8217;s employment is at will and may be terminated by either party at any time, with or without cause or notice. If her employment
is terminated by the Company without Cause (as defined in the CFO Employment Agreement), or she resigns for Good Reason (as defined in
the CFO Employment Agreement), Ms. Gendron may be entitled to: (i) severance equal to six (6) months of her then current base salary,
(ii) payment of any earned but unpaid prior year annual incentive, (iii) partial acceleration of any then unvested stock options (if any)
and performance-based RSUs, and (iv) accrued but unpaid base salary and any accrued, unused vacation, in each case subject to the terms
of the CFO Employment Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the CFO Employment
Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the CFO Employment Agreement,
which is filed as Exhibit 10.1 and incorporated by reference hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Appointment of Chief Accounting Officer</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 8, 2025, the Board appointed
John Dalton, age 43, as&#160;Chief Accounting Officer and Controller&#160;of the Company, effective as of the Effective Date. Prior
to his appointment, Mr. Dalton served as Chief Financial Officer of Jefferies Finance LLC, from July 2023 to September 2025, and
previously served as Vice President and Co-Controller of Jefferies Financial Group Inc., a publicly traded financial services
company listed on the New York Stock Exchange, from 2022 to 2023. Prior to the corporate consolidation of Jefferies Financial Group
Inc. and Jefferies Group LLC, Mr. Dalton served as Vice President, Controller and Chief Accounting Officer of Jefferies Financial
Group Inc. from 2015 to 2022. Mr. Dalton holds a Bachelor of Business Administration from James Madison University and is a
Certified Public Accountant in the Commonwealth of Virginia. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with his appointment as Chief Accounting
Officer, the Company entered into an employment agreement with Mr. Dalton (the &#8220;<b>CAO Employment Agreement</b>&#8221;) dated December
8, 2025. Under the terms of the CAO Employment Agreement, Mr. Dalton will receive an annual base salary of $300,000 and will be eligible
for annual incentive compensation with a target equal to 50% of his annual base salary, based on performance metrics established by the
Board (or its Compensation Committee). Mr. Dalton will be eligible to receive an initial grant of performance-based restricted stock units
with a grant-date value of $600,000. Such award will vest over a four-year period. Subsequent annual performance-based awards may be granted
at the Board&#8217;s discretion, subject to performance metrics established for each grant year. The agreement contains customary confidentiality,
non-compete, non-solicitation, and intellectual property provisions, and may be terminated by either party in accordance with its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Dalton will also be entitled to participate
in the Company&#8217;s employee benefit plans made available to similarly situated employees, as well as to vacation and sick leave in
accordance with Company policy and reimbursement of reasonable business expenses pursuant to the Company&#8217;s expense reimbursement
policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CAO Employment Agreement provides that Mr.
Dalton&#8217;s employment is at will and may be terminated by either party at any time, with or without cause or notice. If his employment
is terminated by the Company without Cause (as defined in the CAO Employment Agreement), or he resigns for Good Reason (as defined in
the CAO Employment Agreement), Mr. Dalton may be entitled to: (i) severance equal to six (6) months of his then-current base salary, (ii)
partial acceleration of any then-unvested stock options (if any) and performance-based RSUs to the extent such awards would have vested
during the six (6) months following termination (subject to satisfaction of applicable performance metrics), and (iii) accrued but unpaid
base salary and any accrued, unused vacation, in each case subject to the terms of the CAO Employment Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the CAO Employment
Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the CAO Employment Agreement,
which is filed as Exhibit 10.2 and incorporated by reference hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01.&#160;Regulation FD&#160;Disclosures.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 8, 2025 the Company issued a press
release announcing the appointment of Ms. Gendron as the Company&#8217;s new Chief Financial Officer, and the appointment of Mr. Dalton
as the Company&#8217;s Chief Accounting Officer, a copy of which is attached to this Current Report on Form 8-K as Exhibit 99.1 and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit 99.1 contains forward-looking statements.
These forward-looking statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult
to predict. Forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Actual outcomes
and results may differ materially from what is expressed in these forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information set forth under Item 7.01 of this
Current Report on Form 8-K (&#8220;Current Report&#8221;), including Exhibit 99.1 attached hereto, is being furnished and shall not be
deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1,
shall not be incorporated by reference into any filing under the&#160;Securities Act of 1933, as amended, or the&#160;Exchange Act, regardless
of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This
Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be
disclosed solely by&#160;Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of Exhibit</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1#</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea026878901ex10-1_kindlymd.htm">Employment Agreement with Teresa Gendron, dated December 8, 2025</a></span></td></tr>
  <tr style="background-color: white">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2#</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea026878901ex10-2_kindlymd.htm">Employment Agreement with John Dalton, dated December 8, 2025</a></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea026878901ex99-1_kindlymd.htm">Press Release, dated December 8, 2025</a></span></td></tr>
  <tr style="background-color: white">
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">#</td><td style="text-align: justify">Indicates a management contract or any compensatory plan, contract
or arrangement.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KINDLY MD, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 37%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: December 8, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By<i>: </i></span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David Bailey</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Bailey</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx9kNFOwjAUhp+AdzhZvCTQzaDJ7nRBYgRdkKC3h+1MFrae5bRDeCTf0q4DvRGbJk3b///+vw2CYTDjh7Iigff75RxWVDcVWoIlFSSkM3KK5PEpBrcu6aM0VlBbvz0bE3Yecp6b0TW6c6/cl4byGMJorG7H0QTUJI4UpItg0N0nrIsyJ21LrAB1DqlwIyVZlGNPWOGBNddHn7QmMSVrhxup/voLIhVG8Mx7/GTZGZjPk2Aw9GMQzITbxqmmB0u6c8K0otrFmd79O32brDWW63glmBNuKnpD6R5pVpy2km3R0OsWhcxL4Z5as361nO1SlDVWLamRUmFK4iULqjckDhmqKArV3antDxnOaLAMzQkOxtOBC+j54AOG0KDAvsuAK58CjfttL/6j/aVqFyr9n3TmfwNA1qWm -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea026878901ex10-1_kindlymd.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT WITH TERESA GENDRON, DATED DECEMBER 8, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Employment Agreement
(this &ldquo;<I>Agreement</I>&rdquo;) is made as of December 8, 2025 and is entered into by and between Kindly MD, Inc. d/b/a Nakamoto
(the &ldquo;<I>Company</I>&rdquo;) and Teresa Gendron (&ldquo;<I>Employee</I>&rdquo;) (collectively with the Company, the &ldquo;<I>Parties</I>&rdquo;;
each of the Parties referred to individually as a &ldquo;<I>Party</I>&rdquo;). In consideration of the promises and mutual covenants and
agreements set forth in this Agreement, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B>EMPLOYMENT</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Title</I></B>. The Company hereby agrees to employ Employee, and Employee hereby accepts such employment,
as Chief Financial Officer reporting to the Chief Executive Officer or a designee of the Chief Executive Officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Principal Place of Employment</I></B>. Employee&rsquo;s principal place of employment shall initially
be Virgina, although time may be spent, as part of performing the services set forth herein, in such other domestic and/or international
locations, as may be reasonably requested by the Company from time to time, for which Employee may be required to travel at the Company&rsquo;s
sole expense, in accordance with its travel policies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B><I>At Will Relationship</I></B>. Employee&rsquo;s employment with the Company shall commence on the
date here. Employee&rsquo;s employment shall be considered &ldquo;at will&rdquo; in nature and, accordingly, either the Company or Employee
may terminate this Agreement and Employee&rsquo;s employment at any time and for any reason, with or without cause or prior notice. Nothing
in this Agreement, including but not limited to Section 3 hereof, shall be construed as, or shall interfere with, abridge, limit, modify,
or amend the &ldquo;at will&rdquo; nature of Employee&rsquo;s employment with Company. Except as set forth in Section 3 of this Agreement,
upon Employee&rsquo;s separation from employment with the Company (for any reason), all compensation and benefits payable or provided
to Employee shall, except as required by applicable law, terminate as of the effective date of Employee&rsquo;s termination (the &ldquo;<I>Termination
Date</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B><I>Duties and Responsibilities</I></B>. During Employee&rsquo;s employment with the Company, Employee
shall at all times: (i) comply with the terms and conditions set forth in this Agreement; (ii) perform and carry out such responsibilities,
duties, and authorities as the Company may direct, designate, request of, or assign to Employee from time to time consistent with Employee&rsquo;s
title, which shall include, but not necessarily be limited to, the services set forth in <B>Exhibit A</B> hereto; (iii) perform the duties
and carry out the responsibilities assigned to the Employee by the Company to the best of Employee&rsquo;s ability, in a trustworthy,
business-like, and efficient manner for the purpose of advancing the business and interests of the Company; (iv) devote sufficient time,
attention, effort, and skill to Employee&rsquo;s position with and the business of the Company; (v) comply with and abide by the Company&rsquo;s
policies, practices, and procedures (as may be amended or otherwise modified from time to time by the Company); and (vi) comply with all
laws, rules, regulations, and licensing requirements of, or that may be applicable to, Employee&rsquo;s employment with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In the event that any term(s) of this
Agreement conflicts with a term(s) of any employee handbook, policy, practice, or procedure adopted or maintained, at any time, by the
Company, the term(s) of this Agreement shall control and supersede such conflicting term(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><B><I>No Conflicts</I></B>. Employee represents and warrants that she is not bound by or subject to any
written or oral agreement, pact, covenant, or understanding with any previous or concurrent employer, or any other party, that would limit,
abridge, restrict, or interfere with, in any way, Employee&rsquo;s ability to perform Employee&rsquo;s duties and obligations hereunder.
Employee further represents and warrants that the performance of Employee&rsquo;s duties and obligations hereunder shall not violate any
written or oral agreement, pact, covenant, or understanding by and between Employee and any previous or concurrent employer, or any other
party. Employee further represents and warrants that she will not use any trade secret, or confidential or proprietary information, of
any of Employee&rsquo;s previous or concurrent employers, or that was obtained, learned, or procured during any period of employment prior
to or concurrent with Employee&rsquo;s employment with the Company, in connection with Employee&rsquo;s employment with the Company or
in the performance of Employee&rsquo;s duties and obligations hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B>COMPENSATION AND BENEFITS</B>. Subject to the terms and conditions of Sections 1 and 3 of this Agreement
and Employee&rsquo;s continued employment with the Company, and in consideration for the services to be provided hereunder by Employee,
the Company hereby agrees to pay or otherwise provide Employee with the following compensation and benefits during Employee&rsquo;s employment
with the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Annual Salary</I></B>. The Company shall pay Employee a base salary equal to $450,000 per year (as
it may be adjusted from time to time, the &ldquo;<I>Annual Salary</I>&rdquo;), less applicable taxes, withholdings, and deductions, and
any other deductions that may be authorized by Employee, from time to time, in accordance with applicable federal, state, and/or local
law. The Annual Salary shall be payable in accordance with the Company&rsquo;s standard payroll practices and procedures, as in effect
from time to time. Employee acknowledges and understands that Employee&rsquo;s position of employment with the Company is considered &ldquo;exempt,&rdquo;
as that term is defined under the Fair Labor Standards Act and applicable state or local law. As an exempt employee, Employee is not eligible
to receive overtime pay.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Notwithstanding the foregoing, the Annual
Salary may be reviewed by the Company from time to time and may be subject to upward or downward adjustment, in the Company&rsquo;s sole
discretion, based upon a review and consideration of various factors, including but not limited to Employee&rsquo;s performance and/or
the Company&rsquo;s overall financial performance; provided, that in the case of a downward adjustment, only in the case that such downward
adjustments are with Employee&rsquo;s consent or applied pursuant to a salary reduction program affecting all or substantially all of
the employees of the Company and that does not adversely affect Employee to a greater extent than other similarly situated employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify"><B><I>Incentive Compensation</I></B>. Employee will be eligible to receive annual incentive compensation
with a target equal to 1<FONT STYLE="font-family: Times New Roman, Times, Serif">50</FONT>% of Annual Salary in accordance with performance
metrics established by the Board or the compensation committee of the Board, in its sole and absolute discretion (the &ldquo;<I>Incentive
Compensation</I>&rdquo;), which may vary from year to year and which shall be provided to or made available to Employee. In order for
Employee to be eligible to receive Incentive Compensation pursuant to this Section 2(b), Employee must remain continuously employed by
the Company through the date of payment of any such earned Incentive Compensation. The Incentive Compensation shall be subject to other
customary terms to be set forth in any corresponding award agreement or applicable plan document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify"><B><I>Annual Performance Award</I></B>. Subject to (i) approval of the Board or the compensation committee
of the Board, which shall be promptly sought, (ii) timely execution of an award agreement (the &ldquo;<I>Award Agreement</I>&rdquo;) and
(iii) the terms and conditions of the Award Agreement, Employee will receive an annual grant of performance-based restricted stock units.
The initial grant shall be calculated by dividing $1,000,000 by the closing trading price of the Company common stock as of the date of
grant (the &ldquo;<I>Initial Annual Performance Award</I>&rdquo;). Subsequent performance-based annual grants of restricted stock units
shall be based on performance metrics established by the Board (or its compensation committee), which metrics may vary from year to year
(the &ldquo;<I>Annual Performance Awards</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Initial Annual Performance Award and
any subsequent Annual Performance Awards (collectively, the &ldquo;<I>Performance Awards</I>&rdquo;) shall each vest over a four (4) year
period, with no vesting during the first twelve (12) months following the grant date (the &ldquo;<I>RSU Cliff Period</I>&rdquo;), and
thereafter twenty-five percent (25%) of the award shall vest upon completion of the RSU Cliff Period, with the remaining seventy-five
percent (75%) vesting in equal quarterly installments over the subsequent three (3) years, subject to Employee&rsquo;s continued employment
with the Company in good standing through each applicable vesting date, other than as otherwise stated (if at all) n the Performance Award
documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Performance Awards shall also be subject
to the achievement of performance milestones established for each grant year by the Board (or its compensation committee). Each Performance
Award shall be subject to other customary terms to be set forth in the corresponding award agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The initial annual grant will be issued
to Employee no later than the end of the next fiscal quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B><I>Benefit Plans</I></B>. Employee shall be entitled to participate in any and all medical insurance,
group health, disability insurance, life insurance, incentive, savings, retirement, and other benefit plans, if any, which are made generally
available to similarly-situated employees of the Company (and subject to eligibility requirements, enrollment criteria, and other terms
and conditions of such plans), and which the Company (or any affiliate maintaining any such arrangement), in its sole discretion, may
at any time amend, modify, or terminate, subject to the terms and conditions of such plans and applicable federal, state, or local law.
Such plans shall include D&amp;O insurance and indemnification in accordance with that provided to other C-suite employees.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><B><I>Vacation and Sick Leave</I></B>. Employee shall be entitled to vacation and sick leave in accordance
with the Company&rsquo;s respective vacation and sick leave policies, as in effect from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><B><I>Expenses</I></B>. Employee shall be entitled to reimbursement for all reasonable expenses that she
incurs in connection with the performance of Employee&rsquo;s duties and obligations hereunder. Upon presentment by Employee of appropriate
and sufficient documentation, as determined in the Company&rsquo;s sole discretion, the Company shall reimburse Employee for all such
expenses in accordance with the Company&rsquo;s expense reimbursement policy, as in effect from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B>EFFECT OF TERMINATION</B>. Employee&rsquo;s employment may be terminated by the Company for Cause (as
defined below) or without Cause or by resignation for any reason. In the event of any such termination, Employee shall only be entitled
to the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Termination of Employment for Any Reason, Resignation by the Employee, or Termination by the Company
for Cause</I></B>. If Employee&rsquo;s employment is terminated for any reason, is terminated by the Company for Cause or Employee resigns
from his employment for any reason, then in full satisfaction of the Company&rsquo;s obligations under this Agreement, Employee shall
be entitled to receive (i) any vacation accrued but unused as of the Termination Date, subject to the Company&rsquo;s policies regarding
vacation pay, and (ii) any Annual Salary earned but unpaid as of the Termination Date (the &ldquo;<I>Accrued Obligations</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Termination by the Company without Cause, or Resignation by the Employee for Good Reason</I></B>.
If Employee&rsquo;s employment is terminated by the Company without Cause or by Employee for Good Reason, subject to Employee executing
and not revoking a general release of all claims against the Company, its subsidiaries, and any of their respective affiliates in a form
to be provided to Employee from the Company (a &ldquo;<I>Release</I>&rdquo;) and the expiration of any applicable revocation period with
respect to the Release within forty-five (45) days after Employee&rsquo;s Termination Date (the last day of the maximum period of time
that the Release can be executed and no longer revocable, the &ldquo;<I>Release Consideration Expiration Date</I>&rdquo;, and the actual
date in which the Release is fully effective and no longer revocable, the &ldquo;<I>Release Effective Date</I>&rdquo;), then in full satisfaction
of the Company&rsquo;s obligations under this Agreement, Employee shall be entitled to receive the following: (i) an amount equal to six
(6) months of then-current Annual Salary, as of the Termination Date, which shall be paid, in equal monthly installments in accordance
with the Company&rsquo;s general payroll practices, with the first installment to be paid on the first payroll date following the effective
date of the Release (the &ldquo;<I>Severance Payment Commencement Date</I>&rdquo;), with any such payments that would have otherwise been
made to Employee following their Termination Date but prior to the Release Effective Date to be paid on the Severance Payment Commencement
Date; (ii) Incentive Compensation for a prior year, if earned but not yet paid; (iii) partial acceleration of any then-unvested stock
options (if any) and Annual Performance Awards as of the Termination Date that would have vested during the six (6) month period immediately
following the date of the Termination Date (provided that, for any performance-based awards, any applicable performance-metrics are satisfied);
and (iii) any Accrued Obligations as of the Termination Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Definition of Cause and Good Reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">For purposes herein, &ldquo;<I>Cause</I>&rdquo; shall mean the occurrence of any one or more of the following
events, as determined in the sole discretion of the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify"><I>Willful Misconduct or Gross Negligence</I>:&nbsp;Employee&rsquo;s willful misconduct, gross negligence,
or material failure to perform the duties and responsibilities of their position (other than as a result of physical or mental incapacity),
after written notice from the Company and a reasonable opportunity to cure, if curable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify"><I>Violation of Policies</I>:&nbsp;Employee&rsquo;s material violation of any written policy, code of
conduct, or procedure of the Company, its subsidiaries, or any of their respective affiliates, including but not limited to those relating
to harassment, discrimination, workplace safety, or substance abuse.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify"><I>Dishonesty or Fraud</I>:&nbsp;Employee&rsquo;s commission of, or participation in, any act of fraud,
dishonesty, embezzlement, misappropriation, or other act of material misconduct with respect to the Company, its subsidiaries, or any
of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify"><I>Criminal Conduct</I>:&nbsp;Employee&rsquo;s indictment for, conviction of, or plea of guilty or nolo
contendere to, a felony or any crime involving moral turpitude, dishonesty, or theft.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(E)</TD><TD STYLE="text-align: justify"><I>Breach of Agreement or Fiduciary Duty</I>:&nbsp;Employee&rsquo;s material breach of this Agreement
or any other written agreement with the Company, its subsidiaries, or any of their respective affiliates, or Employee&rsquo;s breach of
any fiduciary duty owed to the Company, its subsidiaries, or any of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(F)</TD><TD STYLE="text-align: justify"><I>Unauthorized Disclosure</I>:&nbsp;Employee&rsquo;s unauthorized use or disclosure of any confidential
or proprietary information of the Company, its subsidiaries, or any of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">&ldquo;<I>Good Reason</I>&rdquo; shall mean Employee&rsquo;s termination of his employment in accordance
with the next sentence after the occurrence of one or more of the following events without Employee&rsquo;s express written consent: (i)
a material diminishment of Employee&rsquo;s job title; (ii) a material reduction by the Company in Employee&rsquo;s rate of Annual Salary
by more than ten percent (10%) (provided, however that such a reduction in the Holder&rsquo;s base salary pursuant to a salary reduction
program affecting all or substantially all of the employees of the Company and that does not adversely affect the Holder to a greater
extent than other similarly situated employees shall not constitute Good Reason); (iii) a material change in the geographic location of
Employee&rsquo;s primary work facility or location that is requested or initiated by the Company; provided, that a relocation of less
than thirty (30) miles from Employee&rsquo;s then present location will not be considered a material change in geographic location.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B>RESTRICTIVE COVENANTS</B><FONT STYLE="font-size: 10pt">. </FONT>The Parties agree that the Company
and its respective subsidiaries and affiliates are engaged in highly competitive industries and would suffer irreparable harm and incur
substantial damage if Employee were to enter into competition with the Company and its respective subsidiaries and affiliates. Therefore,
in order for the Company to protect their legitimate business interests, Employee covenants and agrees as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during Employee&rsquo;s employment with the Company and for a period of
6 months thereafter (the &ldquo;<I>Restricted Period</I>&rdquo;), anywhere in the United States or any jurisdiction in which the Company
and its subsidiaries and affiliates conduct material business operations (the &ldquo;<I>Restricted Territory</I>&rdquo;), either directly
or indirectly: (i) accept employment with or render services to (whether as an employee, agent, servant, owner, partner, consultant, employee,
independent contractor, representative, director, officer, or stockholder) any person or entity that is a business competitor of the Company
and its subsidiaries and affiliates or entity that competes with the Company and its subsidiaries and affiliates in the field of Bitcoin
treasury management, Bitcoin-native financial services, or public-market digital asset vehicles, or has at any time during Employee&rsquo;s
employment with the Company engaged or attempted to engage in business competition with the Company and its subsidiaries and affiliates,
in a position, capacity, or function that is similar, in title or substance, whether in whole or in part, to any position, capacity, or
function that Employee held with or in which Employee served the Company; or (ii) invest in any person or entity that is a business competitor
of the Company and its subsidiaries and affiliates, or has at any time during Employee&rsquo;s employment with the Company engaged or
attempted to engage in business competition with the Company and subsidiaries and affiliates, except that Employee may own up to one percent
(1%) of any outstanding class of securities of any company registered under Section 12 of the Securities Exchange Act of 1934, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during Employee&rsquo;s employment with the Company and for a period of
12 months thereafter in the Restricted Territory, for any reason, on Employee&rsquo;s own behalf or on behalf of any other person or entity,
by or through any means including but not limited to social media: (i) solicit, invite, induce, cause, or encourage to alter or terminate
Employee&rsquo;s, her, or its business relationship with the Company and its subsidiaries and affiliates, any client, customer, supplier,
vendor, licensee, licensor, or other person or entity that, at any time during Employee&rsquo;s employment with the Company, had a business
relationship with the Company and subsidiaries and affiliates, or any person or entity whose business the Company and its subsidiaries
and affiliates was soliciting or attempting to solicit at the time of Employee&rsquo;s termination, (a) for whom Employee performed services
or with whom Employee had contact during Employee&rsquo;s employment with the Company, or whose business Employee was soliciting or attempting
to solicit at the time of Employee&rsquo;s termination, and (b) with whom Employee did not have a business relationship prior to Employee&rsquo;s
employment with the Company; (ii) solicit, entice, attempt to solicit or entice, or accept business from any such client, customer, supplier,
vendor, licensee, licensor, person, or entity; or (iii) interfere or attempt to interfere with any aspect of the business relationship
between the Company and its subsidiaries and affiliates and any such client, customer, supplier, vendor, licensee, licensor, person, or
entity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during Employee&rsquo;s employment with the Company and for a period of
12 months thereafter in the Restricted Territory, either directly or indirectly, on Employee&rsquo;s own behalf or on behalf of any other
person or entity, by or through any means including but not limited to social media: (i) solicit, invite, induce, cause, or encourage
any director, officer, employee, agent, representative, consultant, or contractor of the Company and its subsidiaries and affiliates to
alter or terminate Employee&rsquo;s, her, or its employment, relationship, or affiliation with the Company and its subsidiaries and affiliates;
(ii) interfere or attempt to interfere with any aspect of the relationship between the Company and its subsidiaries and affiliates and
any such director, officer, employee, agent, representative, consultant, or contractor; or (iii) engage, hire, or employ, or cause to
be engaged, hired, or employed, in any capacity whatsoever, any such director, officer, employee, agent, representative, consultant, or
contractor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Employee covenants and agrees that, during the Restricted Period, Employee shall not make any statement,
written or verbal, in any forum or media, or take any other action or engage in any conduct that disparages the Company and its subsidiaries
and affiliates, their services, products, officers, directors, managers, employees, shareholders, members, investments or agents. The
Company and its subsidiaries and affiliates covenant and agree that, during the Restricted Period, the Company and its subsidiaries and
affiliates shall not make any statement, written or verbal, in any forum or media, or take any other action or engage in any conduct that
disparages Employee. Nothing in this Section 4(d) shall prohibit any Person from (A) testifying truthfully in any legal or administrative
proceeding or otherwise truthfully responding to any other request for information or testimony to which such Person is legally required
to respond; (B) making any truthful statement to the extent necessary to rebut any untrue public statements made by another Person; (C)
making any statement or engaging in any conduct that would constitute a permitted disclosure; (D) making any truthful statement as part
of or in any arbitration or court proceeding that involves such Person; or (E) making any truthful statement or expression of opinion
in connection with requests from third parties for employment references or in connection with discussions involving matters of workplace
concern, such as performance review, bonus determination, or investigation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Employee represents, warrants, agrees,
and understands that: (i) the covenants and agreements set forth in this Section 4 of the Agreement are reasonable in their geographic
scope, temporal duration, and the type and scope of activities they restrict; (ii) the Company&rsquo;s agreement to employ Employee, and
a portion of the compensation to be paid to Employee hereunder, are in consideration for such covenants and Employee&rsquo;s continued
compliance therewith, and constitute adequate and sufficient consideration for such covenants; (iii) Employee shall not raise any issue
of, nor contest or dispute, the reasonableness of the geographic scope, temporal duration, or content of such covenants and agreements
in any proceeding to enforce such covenants and agreements; (iv) the enforcement of any remedy under this Agreement will not prevent Employee
from earning a livelihood, because Employee&rsquo;s past work history and abilities are such that Employee can reasonably expect to find
work in other areas and lines of business; (v) the covenants and agreements set forth in this Section 4 of the Agreement are essential
for the Company&rsquo;s and its subsidiaries and affiliates reasonable protection, are designed to protect the Company&rsquo;s and its
subsidiaries and affiliates legitimate business interests, and are necessary and implemented for legitimate business reasons; and (vi)
in entering into this Agreement, the Company has relied upon Employee&rsquo;s representation that Employee will comply in full with the
covenants and agreements set forth in this Section 4 of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If Employee breaches Section 4(a), 4(b),
or 4(c) above, then the period during which that section remains in effect shall be extended by the length of time during which such breach
continues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B>CONFIDENTIALITY</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Confidential Information</I></B>. Employee acknowledges that during her employment with the Company,
and by the nature of Employee&rsquo;s duties and obligations hereunder, Employee will come into close contact with confidential information
of the Company and its subsidiaries, affiliates, and/or other related entities, as applicable, including but not limited to: trade secrets,
know-how, Intellectual Property (as that term is defined below), business plans, client/customer lists, pricing, sales and marketing information,
products, research, algorithms, market intelligence, services, technologies, concepts, methods, sources, methods of doing business, patterns,
processes, compounds, formulae, programs, devices, tools, compilations of information, development, manufacturing, purchasing, engineering,
computer programs (whether in source code or object code), theories, techniques, procedures, strategies, systems, designs, works of art,
the identity of and any information concerning affiliates or customers, or potential customers, information received from others that
the Company and its subsidiaries and affiliates are obligated to treat as confidential or proprietary, and any other technical, operating,
non-public financial, and other business information that has commercial value, whether relating to the Company, its business, potential
business, or operations, or the business of any of the Company&rsquo;s affiliates, subsidiaries, related entities, clients, customers,
suppliers, vendors, licensees, or licensors, that Employee may develop or of which Employee may acquire knowledge during Employee&rsquo;s
employment with the Company, or from Employee&rsquo;s colleagues while working for the Company, whether prior to, during, or subsequent
to Employee&rsquo;s execution of this Agreement, and all other business affairs, methods, and information not readily available to the
public (collectively, &ldquo;<I>Confidential Information</I>&rdquo;). Confidential Information does not include: (i) Employee&rsquo;s
general skills and experience; (ii) information that was lawfully in Employee&rsquo;s possession prior to Employee&rsquo;s employment
with the Company (other than through breach by a third party of any confidentiality obligation to the Company and its subsidiaries and
affiliates); (iii) information that is or becomes publicly available without any direct or indirect act or omission on Employee&rsquo;s
part; (iv) information that is required to be disclosed pursuant to any applicable law, regulation, judicial or administrative order or
decree, or request by other regulatory organization having authority pursuant to the law; provided, however, that, except as set forth
in and subject to Section 5(b) of this Agreement, Employee shall first have given reasonable notice to the Company prior to making such
disclosure; or (v) information that is generally known within the industries or trades in which the Company and its subsidiaries and affiliates
transact business.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The term &ldquo;<I>Intellectual Property</I>&rdquo;
means all discoveries, procedures, designs, creations, developments, improvements, methods, techniques, practices, methodologies, data
models, databases, scripts, know-how, processes, algorithms, application program interfaces, software programs, software source documents
and training manuals, codes, formulae, works of authorship, mask-works, reports, memoranda, ideas, inventions, customer lists, business
and/or financial information, and contributions of any kind, whether or not they are patentable, registrable, or protectable under federal
or state patent, copyright, or trade secret laws, or similar statutes, or protectable under common-law principles, and regardless of their
form or state of development, that are made, conceived, generated, or reduced to practice by Employee, in whole or in part, either alone
or jointly with others, or while Employee was serving as an officer, director, employee, or consultant of, or in any other capacity with,
the Company. Notwithstanding anything else in this Agreement, and as it used in this Section 5, the term &ldquo;Intellectual Property&rdquo;
excludes any software program, application program interface, equipment, supplies, resources, facilities, data, products, information,
materials, or trade secrets used by the Company and its subsidiaries and affiliates, and which was developed entirely on Employee&rsquo;s
own time, unless said Intellectual Property: (i) relates to the Company&rsquo;s and its subsidiaries and affiliates business or potential
business; or (ii) results from tasks assigned to Employee by the Company or from work performed by Employee for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Employee acknowledges and agrees that
each and every part of the Company&rsquo;s and its subsidiaries and affiliates Confidential Information: (a) has been developed by the
Company and its subsidiaries and affiliates at significant effort and expense; (b) is sufficiently secret to derive economic value from
not being generally known to other parties; (c) is proprietary to and a trade secret of the Company and its subsidiaries and affiliates
and, as such, is a valuable, special, and unique asset of the Company and its subsidiaries and affiliates; and (d) constitutes a protectable
business interest of the Company and its subsidiaries and affiliates. Employee further acknowledges and agrees that any unauthorized use
or disclosure of any Confidential Information by Employee will cause irreparable harm and loss to the Company and its subsidiaries and
affiliates. Employee acknowledges and agrees that the Company and its subsidiaries and affiliates own the Confidential Information. Employee
agrees not to dispute, contest, or deny any such ownership rights either during or after Employee&rsquo;s employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In recognition of the foregoing, and except
as set forth in and subject to Section 5(b) of this Agreement, Employee covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">Employee will use Confidential Information only in the performance of Employee&rsquo;s duties and obligations
hereunder for the Company. Employee will not use Confidential Information, directly or indirectly, at any time during or after Employee&rsquo;s
employment with the Company, for Employee&rsquo;s personal benefit, for the benefit of any other person or entity, or in any manner adverse
to the interests of the and its subsidiaries and affiliates. Further, Employee will keep secret all Confidential Information and will
not make use of, divulge, or otherwise disclose Confidential Information, directly or indirectly, to anyone outside of the Company, except
with the Company&rsquo;s prior written consent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">Employee will take all necessary and reasonable steps to protect Confidential Information from being disclosed
to anyone within the Company who does not have a need to know the information and to anyone outside of the Company, except with the Company&rsquo;s
prior written consent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify">Employee shall not at any time remove, copy, download, or transmit any information from the Company and
its subsidiaries and affiliates during the term of this Agreement, except for the benefit of the Company and in accordance with this Agreement
and the Company&rsquo;s policies; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)</FONT></TD><TD STYLE="text-align: justify">Promptly upon Employee&rsquo;s termination, and in any event no later than three (3) business days after
Employee&rsquo;s employment with the Company ceases, Employee shall return to the Company and its subsidiaries and affiliates any and
all Confidential Information in Employee&rsquo;s possession, custody, or control, including but not limited to all memoranda, notes, records,
plans, reports, forecast, marketing information, financial records and information, employee or contractor records and files, client lists,
training materials, trade secrets, and all other documents (and all copies thereof), whether in electronic or hard copy form, which Employee
obtained while employed by the Company or otherwise serving or acting on behalf of the Company, or which Employee may then possess or
have under Employee&rsquo;s control. Employee may retain documents evidencing her terms of employment and compensation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B>Duration of Covenant</B>. Employee acknowledges and agrees that Employee&rsquo;s obligations under
this Section 5 of the Agreement shall remain in effect for the duration of Employee&rsquo;s employment relationship with the Company or
its subsidiaries or affiliates and for a period of five (5) years thereafter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Notwithstanding the foregoing, nothing
in this Agreement shall be construed as, or shall interfere with, abridge, limit, restrain, or restrict Employee&rsquo;s (or Employee&rsquo;s
attorney&rsquo;s) right, without prior authorization from or notification to the Company: (i) to engage in any activity or conduct or
any provision of the National Labor Relations Act (and, in fact, this Section 5 of the Agreement shall not apply to, among other things,
any discussion of company wages, hours, and working conditions as protected by the National Labor Relations Act and/or any other applicable
federal, state, or local law); (ii) to communicate with any federal, state, or local government agency charged with the enforcement and/or
investigation of claims of discrimination, harassment, retaliation, improper wage payments, or any other unlawful employment practices
under federal, state, or local law, or to file a charge, claim, or complaint with, or participate in or cooperate with any investigation
or proceeding conducted by, any such agency; (iii) to report possible violations of federal, state, or local law or regulation to any
government agency or entity, including but not limited, to the extent applicable, to the U.S. Department of Labor, the Department of Justice,
the Securities and Exchange Commission (the &ldquo;<I>SEC</I>&rdquo;), the Congress, and/or any agency Inspector General, or make other
disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation; or (iv) to communicate
directly with, respond to any inquiry from, or provide testimony before, to the extent applicable, the SEC, the Financial Industry Regulatory
Authority, any other self-regulatory organization, or any other federal, state, or local regulatory authority, regarding this Agreement
or its underlying facts or circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In addition, Employee shall not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (i) in
confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the
purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit
or other proceeding, if such filing is made under seal. Further, in the event that Employee files a lawsuit for retaliation by the Company
for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&rsquo;s attorney and use the trade secret
information in the court proceeding, if Employee: (A) files any document containing the trade secret under seal; and (B) does not disclose
the trade secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">To the extent that this Agreement conflicts
with the federal Speak Out Act (Public Law No: 117-224), said act shall control and supersede the conflicting portion of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B>Retention of All Other Rights</B>. Employee&rsquo;s obligations under this Section 5 of the Agreement
are in addition to, and not in place or lieu of, any other statutory or common law obligations that Employee may have with regard to the
maintenance, preservation, protection, use, and/or disclosure of Confidential Information, and the Company specifically reserves all rights
it may have against Employee should Employee violate any such statutory or common law obligations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B>INJUNCTIVE RELIEF</B>. Employee agrees that it would be difficult to measure any damages caused to
the Company and its subsidiaries and affiliates which might result from any breach by Employee of the covenants and agreements set forth
in Sections 4 and 5 of this Agreement, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly,
and notwithstanding any other provision of this Agreement, Employee agrees that if Employee breaches, or the Company and its subsidiaries
and affiliates reasonably believe that Employee is likely to breach, Sections 4 or 5 of this Agreement, the Company and its subsidiaries
and affiliates shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable
relief to restrain any such breach, without showing or proving any actual damage to the Company and its subsidiaries and affiliates. Any
award or relief to the Company and its subsidiaries and affiliates may, in the discretion of the court, include the Company&rsquo;s and
its subsidiaries and affiliates costs and expenses of enforcement (including reasonable attorneys&rsquo; fees, court costs, and expenses).
Nothing contained in this Section 6 of the Agreement or in any other provision of the Agreement shall restrict or limit in any manner
the Company&rsquo;s and its subsidiaries and affiliates right to seek and obtain any form of relief, legal or equitable, and shall not
waive the Company&rsquo;s and its subsidiaries and affiliates right to any other relief related to any dispute arising out of this Agreement
or related to Employee&rsquo;s employment with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B>NOTICES</B>. Any notice or other communication required or permitted to be given hereunder shall be
in writing and shall be deemed to have been given (i) when delivered personally or by hand (with written confirmation of receipt); (ii)
if sent by a nationally-recognized overnight courier, on the date received by the addressee (with written confirmation of receipt); or
(iii) on the date sent by electronic mail or facsimile (with confirmation of transmission), to the recipient(s) and address(es) specified
below (or to such other recipient and/or address as either Party may, from time to time, designate in writing in accordance with the terms
and conditions of this Agreement).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B>LEGAL REPRESENTATION</B>. Employee acknowledges that she was advised to consult with, and has had ample
opportunity to receive the advice of, independent legal counsel before executing this Agreement &ndash; and the Company hereby advises
Employee to do so &ndash; and that Employee has fully exercised that opportunity to the extent Employee desired. Employee acknowledges
that Employee had ample opportunity to consider this Agreement and to receive an explanation from such legal counsel of the legal nature,
effect, ramifications, and consequences of this Agreement. Employee warrants that Employee has carefully read this Agreement, that Employee
understands completely its contents, that Employee understands the significance, nature, effect, and consequences of signing it, and that
Employee has agreed to and signed this Agreement knowingly and voluntarily of Employee&rsquo;s own free will, act, and deed, and for full
and sufficient consideration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B>ENTIRE AGREEMENT; AMENDMENT</B>. This Agreement, together with all exhibits and schedules annexed hereto,
including but not limited the Plan, constitutes the entire agreement between the Parties relating to the subject matter hereof, and supersedes
all prior agreements and understandings, whether oral or written, with respect to the same. In entering into and performing under this
Agreement, neither the Company nor Employee has relied upon any promises, representations, or statements except as expressly set forth
herein. No modification, alteration, amendment, revision of, or supplement to this Agreement shall be valid or effective unless the same
is memorialized in a writing signed by both by Employee and a duly-authorized representative or agent of the Company. Neither e-mail correspondence,
text messages, nor any other electronic communications constitutes a writing for purposes of this Section 10 of the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B>GOVERNING LAW</B>. This Agreement shall in all respects be interpreted, enforced, and governed by and
in accordance with the internal substantive laws (and not the laws of choice of laws) of the State of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B>ASSIGNMENT</B>. This Agreement shall not be assignable by Employee, but shall be binding upon Employee
and upon Employee&rsquo;s heirs, administrators, representatives, executors, and successors. This Agreement shall be freely assignable
by the Company without restriction and, without limitation of the foregoing, shall be deemed automatically assigned by the Company with
Employee&rsquo;s consent in the event of any sale, merger, share exchange, consolidation, or other business reorganization. This Agreement
shall inure to the benefit of the Company and its successors and assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B>SEVERABILITY</B>. If one or more of the provisions of this Agreement is deemed void by law, then the
remaining provisions shall continue with full force and effect and, if legally permitted, such offending provision or provisions shall
be replaced with an enforceable provision or enforceable provisions that as nearly as possible effects the Parties&rsquo; intent. Without
limiting the generality of the foregoing, the Parties hereby expressly state their intent that, to the extent any provision of this Agreement
is deemed unenforceable due to the scope, whether geographic, temporal, or otherwise, being deemed excessive, unreasonable, and/or overbroad,
the court, person, or entity rendering such opinion regarding the scope shall modify such provision(s), or shall direct or permit the
Parties to modify such provision(s), to the minimum extent necessary to cause such provision(s) to be enforceable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B>SURVIVAL</B>. Upon the termination or expiration of this Agreement, the entire Agreement shall survive
such termination or expiration, and shall continue, with full force and effect, in accordance with their respective terms and conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><B>WAIVER</B>. The failure of either Party to insist, in any one or more instances, upon the performance
of any of the terms, covenants, or conditions of this Agreement or to exercise any right hereunder, shall not be construed as a waiver
or relinquishment of the future performance of any rights, and the obligations of the Party with respect to such future performance shall
continue with full force and effect. No waiver of any such right will have effect unless given in a writing signed by the Party against
whom the waiver is to be enforced.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B>COMPLIANCE WITH SECTION 409A OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (&ldquo;SECTION 409A&rdquo;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">It is the intention of the Parties that all payments and benefits under this Agreement (and any amendment
hereto) shall be made and provided in a manner that is either exempt from or compliant with Section 409A of the Internal Revenue Code
and the rules, regulations and notices thereunder (&ldquo;<I>Code Section 409A</I>&rdquo;). Any ambiguity in this Agreement (or any amendment
hereto) shall be interpreted to comply with the above. Employee acknowledges that the Company has made no representations and makes no
guarantee as to the treatment of the compensation and benefits provided hereunder and Employee has been advised to obtain Employee&rsquo;s
own tax advice, and further, Employees agrees that the Company and the Company&rsquo;s officers, employees, agents, equity holders, successors,
affiliates and representatives shall have no liability for any of the payments or benefits under this Agreement or any other arrangement
failing to be exempt from or to comply with Code Section 409A. Each amount or benefit payable pursuant to this Agreement (and any amendment
hereto) shall be a separate payment for purposes of Code Section 409A. For all purposes of this Agreement, any iteration of the word &ldquo;termination&rdquo;
(e.g., &ldquo;terminated&rdquo;) with respect to Employee&rsquo;s employment shall mean a separation from service within the meaning of
Code Section 409A. Without limiting the generality of the foregoing, for purposes of this Agreement, Employee shall be considered to have
a termination of employment only if such termination is a &ldquo;separation from service&rdquo; within the meaning of Code Section 409A.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">To the extent that the reimbursement of any benefits or the provision of any in-kind kind benefits pursuant
to this Agreement is subject to Code Section 409A: (a) the amount of such expenses eligible for reimbursement, or in-kind benefits to
be provided hereunder during any calendar year shall not affect the amount of such expenses eligible for reimbursement or in-kind benefits
to be provided hereunder in any other calendar year; (b) all such expenses eligible for reimbursement hereunder shall be paid to the Employee
no later than December 31<SUP>st</SUP> of the calendar year following the calendar year in which such expenses were incurred; and (c)
Employee&rsquo;s right to receive any such reimbursements or in-kind benefits shall not be subject to liquidation or exchange for any
other benefits.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Notwithstanding anything in this Agreement to the contrary, in the event the stock of the Company (or
its successor) is publicly traded on an establishes securities market or otherwise and the Employee is a &ldquo;specified employee&rdquo;
(as determined under the Company&rsquo;s administrative procedure for such determinations, in accordance with Code Section 409A) at the
time of Employee&rsquo;s termination of employment, any payments under this Agreement that are deemed to be deferred compensation subject
to Code Section 409A and payable in connection with a separation from service shall not be paid or begin payment until the earlier of
(a) Employee&rsquo;s death or (b) the first day following the six (6) month anniversary of the Termination Date. If the payment of any
amounts under this Agreement are delayed as a result of the previous sentence, on the first day following the end of the six (6) month
period, the Company shall pay Employee a lump sum amount equal to the cumulative amounts that would have otherwise been previously paid
to Employee under this Agreement during such six (6) month period, without interest thereon. To the extent permitted under Code Section
409A, any separate payment or benefits under this Agreement or otherwise shall not be &ldquo;deferred compensation&rdquo; subject to Code
Section 409A and the six-month delay provided in this subsection, to the extent provided in the exceptions in Treasury Regulation Section
1.409A-1(b)(4) and (b)(9) and any other applicable exception or provision under Code Section 409A.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><B>TAXES</B>. The Parties acknowledge and agree that the Company may withhold from any amounts payable
under this Agreement such federal, state, local, and foreign taxes and withholdings as may be required to be withheld pursuant to any
applicable law, rule, or regulation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><B>SECTION HEADINGS</B>. The section headings used in this Agreement are included solely for convenience,
and shall not affect, or be used in connection with, the interpretation of this Agreement. Any reference to any gender in this Agreement
shall include, where appropriate, any other gender.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><B>COUNTERPARTS</B>. This Agreement may be executed in one or more counterparts, each of which will be
deemed to be an original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Parties have
executed this Agreement as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY</B>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Kindly MD, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Amanda Fabiano</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amanda Fabiano</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EMPLOYEE</B>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;/s/ Teresa Gendron</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Teresa Gendron</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Employment Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Description of the Duties and Responsibilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee shall provide to the Company the following duties and responsibilities
(including, as applicable, preparatory work and revisions), which may be amended from time to time by the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;<FONT STYLE="font-family: Symbol"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Develop and execute the company&rsquo;s long-term financial strategy aligned
with corporate objectives.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provide strategic insight to the CEO and Board on financial performance,
capital markets, and risk.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Oversee preparation, accuracy, and timely filing of all SEC reports, ensuring
full compliance with GAAP, SEC regulations, and exchange rules.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maintain and enhance internal controls, including SOX-related processes,
and ensure adherence to all audit, tax, regulatory, and disclosure requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lead all accounting, treasury, FP&amp;A, audit, tax, and financial operations
functions, implementing systems and processes that ensure accuracy and scalability.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Manage relationships with investors, analysts, banks, and other capital-markets
stakeholders, including activities related to capital raising and balance-sheet management.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Oversee budgeting, forecasting, and long-range financial planning, delivering
actionable insights to guide company decision-making.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Identify and manage financial, operational, and market risks, and support
Board committees with timely and transparent reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Build, mentor, and oversee the finance and accounting team, ensuring strong
leadership, accountability, and succession planning.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lead financial due diligence, modeling, and integration efforts related to
mergers, acquisitions, partnerships, and divestitures.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Uphold the highest standards of confidentiality, ethics, and fiduciary responsibility
associated with public-company financial leadership.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Serve as primary management liaison to the Audit Committee, ensuring timely
delivery of financial reports, audit updates, risk assessments, and disclosures, and facilitating clear, transparent communication between
management, external auditors, and the Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea026878901ex10-2_kindlymd.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT WITH JOHN DALTON, DATED DECEMBER 8, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Employment Agreement
(this &ldquo;<I>Agreement</I>&rdquo;) is made as of December 8, 2025 and is entered into by and between Kindly MD, Inc. d/b/a Nakamoto
(the &ldquo;<I>Company</I>&rdquo;) and John Dalton (&ldquo;<I>Employee</I>&rdquo;) (collectively with the Company, the &ldquo;<I>Parties</I>&rdquo;;
each of the Parties referred to individually as a &ldquo;<I>Party</I>&rdquo;). In consideration of the promises and mutual covenants and
agreements set forth in this Agreement, the Parties hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B>EMPLOYMENT</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Title</I></B>. The Company hereby agrees to employ Employee, and Employee hereby accepts such employment,
as Controller and Chief Accounting Officer reporting to the Chief Operating Officer or the Chief Operating Officer&rsquo;s designee (<I>e.g.</I>,
the Chief Financial Officer).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Principal Place of Employment</I></B>. Employee&rsquo;s principal place of employment shall initially
be New Jersey, although substantial time may be spent, as part of performing the services set forth herein, in such other domestic and/or
international locations, as may be reasonably requested by the Company from time to time, for which Employee may be required to travel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B><I>At Will Relationship</I></B>. Employee&rsquo;s employment with the Company shall commence on the
date here. Employee&rsquo;s employment shall be considered &ldquo;at will&rdquo; in nature and, accordingly, either the Company or Employee
may terminate this Agreement and Employee&rsquo;s employment at any time and for any reason, with or without cause or prior notice. Nothing
in this Agreement, including but not limited to Section 3 hereof, shall be construed as, or shall interfere with, abridge, limit, modify,
or amend the &ldquo;at will&rdquo; nature of Employee&rsquo;s employment with Company. Except as set forth in Section 3 of this Agreement,
upon Employee&rsquo;s separation from employment with the Company (for any reason), all compensation and benefits payable or provided
to Employee shall, except as required by applicable law, terminate as of the effective date of Employee&rsquo;s termination (the &ldquo;<I>Termination
Date</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B><I>Duties and Responsibilities</I></B>. During Employee&rsquo;s employment with the Company, Employee
shall at all times: (i) comply with the terms and conditions set forth in this Agreement; (ii) perform and carry out such responsibilities,
duties, and authorities as the Company may direct, designate, request of, or assign to Employee from time to time, which shall include,
but not necessarily be limited to, the services set forth in <B><I>Exhibit A</I></B> hereto; (iii) perform the duties and carry out the
responsibilities assigned to the Employee by the Company to the best of his ability, in a trustworthy, business-like, and efficient manner
for the purpose of advancing the business and interests of the Company; (iv) devote sufficient time, attention, effort, and skill to his
position with and the business of the Company; (v) comply with and abide by the Company&rsquo;s policies, practices, and procedures (as
may be amended or otherwise modified from time to time by the Company); and (vi) comply with all laws, rules, regulations, and licensing
requirements of, or that may be applicable to, his employment with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In the event that any term(s) of this
Agreement conflicts with a term(s) of any employee handbook, policy, practice, or procedure adopted or maintained, at any time, by the
Company, the term(s) of this Agreement shall control and supersede such conflicting term(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><B><I>No Conflicts</I></B>. Employee represents and warrants that he is not bound by or subject to any
written or oral agreement, pact, covenant, or understanding with any previous or concurrent employer, or any other party, that would limit,
abridge, restrict, or interfere with, in any way, his ability to perform his duties and obligations hereunder. Employee further represents
and warrants that the performance of his duties and obligations hereunder shall not violate any written or oral agreement, pact, covenant,
or understanding by and between him and any previous or concurrent employer, or any other party. Employee further represents and warrants
that he will not use any trade secret, or confidential or proprietary information, of any of his previous or concurrent employers, or
that was obtained, learned, or procured during any period of employment prior to or concurrent with his employment with the Company, in
connection with his employment with the Company or in the performance of his duties and obligations hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B>COMPENSATION AND BENEFITS</B>. Subject to the terms and conditions of Sections 1 and 3 of this Agreement
and Employee&rsquo;s continued employment with the Company, and in consideration for the services to be provided hereunder by Employee,
the Company hereby agrees to pay or otherwise provide Employee with the following compensation and benefits during his employment with
the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Annual Salary</I></B>. The Company shall pay Employee a base salary equal to $300,000 per year (as
it may be adjusted from time to time, the &ldquo;<I>Annual Salary</I>&rdquo;), less applicable taxes, withholdings, and deductions, and
any other deductions that may be authorized by Employee, from time to time, in accordance with applicable federal, state, and/or local
law. The Annual Salary shall be payable in accordance with the Company&rsquo;s standard payroll practices and procedures, as in effect
from time to time. Employee acknowledges and understands that his position of employment with the Company is considered &ldquo;exempt,&rdquo;
as that term is defined under the Fair Labor Standards Act and applicable state or local law. As an exempt employee, Employee is not eligible
to receive overtime pay.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Notwithstanding the foregoing, the Annual
Salary may be reviewed by the Company from time to time and may be subject to upward or downward adjustment, in the Company&rsquo;s sole
discretion, based upon a review and consideration of various factors, including but not limited to Employee&rsquo;s performance and/or
the Company&rsquo;s overall financial performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify"><B><I>Incentive Compensation</I></B>. Employee will be eligible to receive annual incentive compensation
with a target equal to <FONT STYLE="font-family: Times New Roman, Times, Serif">50</FONT>% of Annual Salary in accordance with performance
metrics established by the Board or the compensation committee of the Board, in its sole and absolute discretion (the &ldquo;<I>Incentive
Compensation</I>&rdquo;), which may vary from year to year. In order for Employee to be eligible to receive Incentive Compensation pursuant
to this Section 2(b), Employee must remain continuously employed by the Company through the date of payment of any such earned Incentive
Compensation. The Incentive Compensation shall be subject to other customary terms to be set forth in any corresponding award agreement
or applicable plan document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify"><B><I>Annual Performance Award</I></B>. Subject to (i) approval of the Board or the compensation committee
of the Board, (ii) timely execution of an award agreement (the &ldquo;<I>Award Agreement</I>&rdquo;) and (iii) the terms and conditions
of the Award Agreement, Employee will be eligible to receive an annual grant of performance-based restricted stock units. The initial
grant shall be calculated by dividing $600,000 by the closing trading price of the Company common stock as of the date of grant (the &ldquo;<I>Initial
Annual Performance Award</I>&rdquo;). Subsequent performance-based annual grants of restricted stock units shall be based on performance
metrics established by the Board (or its compensation committee), which metrics may vary from year to year (the &ldquo;<I>Annual Performance
Awards</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Initial Annual Performance Award and
any subsequent Annual Performance Awards (collectively, the &ldquo;<I>Performance Awards</I>&rdquo;) shall each vest over a four (4) year
period, with no vesting during the first twelve (12) months following the grant date (the &ldquo;<I>RSU Cliff Period&rdquo;</I>), and
thereafter twenty-five percent (25%) of the award shall vest upon completion of the RSU Cliff Period, with the remaining seventy-five
percent (75%) vesting in equal quarterly installments over the subsequent three (3) years, subject to Employee&rsquo;s continued employment
with the Company in good standing through each applicable vesting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Performance Awards shall also be subject
to the achievement of performance milestones established for each grant year by the Board (or its compensation committee). Each Performance
Award shall be subject to other customary terms to be set forth in the corresponding award agreement and the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Subject to the conditions set forth in
the first paragraph of this Section 2(c), the Company intends for the initial annual grant will be issued to Employee no later than the
end of this fiscal quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><B><I>Benefit Plans</I></B>. Employee shall be entitled to participate in any and all medical insurance,
group health, disability insurance, life insurance, incentive, savings, retirement, and other benefit plans, if any, which are made generally
available to similarly-situated employees of the Company (and subject to eligibility requirements, enrollment criteria, and other terms
and conditions of such plans), and which the Company (or any affiliate maintaining any such arrangement), in its sole discretion, may
at any time amend, modify, or terminate, subject to the terms and conditions of such plans and applicable federal, state, or local law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><B><I>Vacation and Sick Leave</I></B>. Employee shall be entitled to vacation and sick leave in accordance
with the Company&rsquo;s respective vacation and sick leave policies, as in effect from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><B><I>Expenses</I></B>. Employee shall be entitled to reimbursement for all reasonable expenses that he
incurs in connection with the performance of his duties and obligations hereunder. Upon presentment by Employee of appropriate and sufficient
documentation, as determined in the Company&rsquo;s sole discretion, the Company shall reimburse Employee for all such expenses in accordance
with the Company&rsquo;s expense reimbursement policy, as in effect from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B>EFFECT OF TERMINATION</B>. Employee&rsquo;s employment may be terminated by the Company for Cause (as
defined below) or without Cause or by resignation for any reason. In the event of any such termination, Employee shall only be entitled
to the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Termination of Employment for Any Reason, Resignation by the Employee, or Termination by the Company
for Cause</I></B>. If Employee&rsquo;s employment is terminated for any reason, is terminated by the Company for Cause or Employee resigns
from his employment for any reason, then in full satisfaction of the Company&rsquo;s obligations under this Agreement, Employee shall
be entitled to receive (i) any vacation accrued but unused as of the Termination Date, subject to the Company&rsquo;s policies regarding
vacation pay, and (ii) any Annual Salary earned but unpaid as of the Termination Date (the &ldquo;<I>Accrued Obligations</I>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Termination by the Company without Cause, or Resignation by the Employee for Good Reason</I></B>.
If Employee&rsquo;s employment is terminated by the Company without Cause or by Employee for Good Reason, subject to Employee executing
and not revoking a general release of all claims against the Company, its subsidiaries, and any of their respective affiliates in a form
to be provided to Employee from the Company (a &ldquo;<I>Release</I>&rdquo;) and the expiration of any applicable revocation period with
respect to the Release within forty-five (45) days after Employee&rsquo;s Termination Date (the last day of the maximum period of time
that the Release can be executed and no longer revocable, the &ldquo;<I>Release Consideration Expiration Date</I>&rdquo;, and the actual
date in which the Release is fully effective and no longer revocable, the &ldquo;<I>Release Effective Date</I>&rdquo;), then in full satisfaction
of the Company&rsquo;s obligations under this Agreement, Employee shall be entitled to receive the following: (i) an amount equal to six
(6) months of then-current Annual Salary, as of the Termination Date, which shall be paid, in equal monthly installments in accordance
with the Company&rsquo;s general payroll practices, with the first installment to be paid on the first payroll date following the effective
date of the Release (the &ldquo;<I>Severance Payment Commencement Date</I>&rdquo;), with any such payments that would have otherwise been
made to Employee following their Termination Date but prior to the Release Effective Date to be paid on the Severance Payment Commencement
Date; (ii) partial acceleration of any then-unvested stock options and Annual Performance Awards as of the Termination Date that would
have vested during the six (6) month period immediately following the date of the Termination Date (provided that, for any performance-based
awards, any applicable performance-metrics are satisfied); and (iii) any Accrued Obligations as of the Termination Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">For purposes herein, &ldquo;<I>Cause</I>&rdquo; shall mean the occurrence of any one or more of the following
events, as determined in the sole discretion of the Company:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><I>Willful Misconduct or Gross Negligence</I>:&nbsp;Employee&rsquo;s willful misconduct, gross negligence,
or material failure to perform the duties and responsibilities of their position (other than as a result of physical or mental incapacity),
after written notice from the Company and a reasonable opportunity to cure, if curable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify"><I>Violation of Policies</I>:&nbsp;Employee&rsquo;s material violation of any written policy, code of
conduct, or procedure of the Company, its subsidiaries, or any of their respective affiliates, including but not limited to those relating
to harassment, discrimination, workplace safety, or substance abuse.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify"><I>Dishonesty or Fraud</I>:&nbsp;Employee&rsquo;s commission of, or participation in, any act of fraud,
dishonesty, embezzlement, misappropriation, or other act of material misconduct with respect to the Company, its subsidiaries, or any
of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify"><I>Criminal Conduct</I>:&nbsp;Employee&rsquo;s indictment for, conviction of, or plea of guilty or nolo
contendere to, a felony or any crime involving moral turpitude, dishonesty, or theft.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify"><I>Breach of Agreement or Fiduciary Duty</I>:&nbsp;Employee&rsquo;s material breach of this Agreement
or any other written agreement with the Company, its subsidiaries, or any of their respective affiliates, or Employee&rsquo;s breach of
any fiduciary duty owed to the Company, its subsidiaries, or any of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify"><I>Unauthorized Disclosure</I>:&nbsp;Employee&rsquo;s unauthorized use or disclosure of any confidential
or proprietary information of the Company, its subsidiaries, or any of their respective affiliates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">&ldquo;<I>Good Reason</I>&rdquo; shall mean Employee&rsquo;s termination of his employment in accordance
with the next sentence after the occurrence of one or more of the following events without Employee&rsquo;s express written consent: (i)
a material diminishment of Employee&rsquo;s job title; (ii) a material reduction by the Company in Employee&rsquo;s rate of Annual Salary
by more than ten percent (10%) (provided, however that such a reduction in the Holder&rsquo;s base salary pursuant to a salary reduction
program affecting all or substantially all of the employees of the Company and that does not adversely affect the Holder to a greater
extent than other similarly situated employees shall not constitute Good Reason); (iii) a material change in the geographic location of
Employee&rsquo;s primary work facility or location that is requested or initiated by the Company; provided, that a relocation of less
than thirty (30) miles from Employee&rsquo;s then present location will not be considered a material change in geographic location.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B>RESTRICTIVE COVENANTS</B><FONT STYLE="font-size: 10pt">. </FONT>The Parties agree that the Company
and its respective subsidiaries and affiliates are engaged in highly competitive industries and would suffer irreparable harm and incur
substantial damage if Employee were to enter into competition with the Company and its respective subsidiaries and affiliates. Therefore,
in order for the Company to protect their legitimate business interests, Employee covenants and agrees as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during his employment with the Company and for a period of 6 months thereafter
(the &ldquo;<I>Restricted Period</I>&rdquo;), anywhere in the United States or any jurisdiction in which the Company and its subsidiaries
and affiliates conduct material business operations (the &ldquo;<I>Restricted Territory</I>&rdquo;), either directly or indirectly: (i)
accept employment with or render services to (whether as an agent, servant, owner, partner, consultant, employee, independent contractor,
representative, director, officer, or stockholder) any person or entity that is a business competitor of the Company and its subsidiaries
and affiliates or entity that competes with the Company and its subsidiaries and affiliates in the field of Bitcoin treasury management,
Bitcoin-native financial services, or public-market digital asset vehicles, or has at any time during Employee&rsquo;s employment with
the Company engaged or attempted to engage in business competition with the Company and its subsidiaries and affiliates, in a position,
capacity, or function that is similar, in title or substance, whether in whole or in part, to any position, capacity, or function that
Employee held with or in which Employee served the Company; or (ii) invest in any person or entity that is a business competitor of the
Company and its subsidiaries and affiliates, or has at any time during Employee&rsquo;s employment with the Company engaged or attempted
to engage in business competition with the Company and subsidiaries and affiliates, except that Employee may own up to one percent (1%)
of any outstanding class of securities of any company registered under Section 12 of the Securities Exchange Act of 1934, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during his employment with the Company and for a period of 12 months thereafter
in the Restricted Territory, for any reason, on his own behalf or on behalf of any other person or entity, by or through any means including
but not limited to social media: (i) solicit, invite, induce, cause, or encourage to alter or terminate his, her, or its business relationship
with the Company and its subsidiaries and affiliates, any client, customer, supplier, vendor, licensee, licensor, or other person or entity
that, at any time during Employee&rsquo;s employment with the Company, had a business relationship with the Company and subsidiaries and
affiliates, or any person or entity whose business the Company and its subsidiaries and affiliates was soliciting or attempting to solicit
at the time of Employee&rsquo;s termination, (a) for whom Employee performed services or with whom Employee had contact during his employment
with the Company, or whose business Employee was soliciting or attempting to solicit at the time of Employee&rsquo;s termination, and
(b) with whom Employee did not have a business relationship prior to his employment with the Company; (ii) solicit, entice, attempt to
solicit or entice, or accept business from any such client, customer, supplier, vendor, licensee, licensor, person, or entity; or (iii)
interfere or attempt to interfere with any aspect of the business relationship between the Company and its subsidiaries and affiliates
and any such client, customer, supplier, vendor, licensee, licensor, person, or entity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Employee shall not, at any time during his employment with the Company and for a period of 12 months thereafter
in the Restricted Territory, either directly or indirectly, on his own behalf or on behalf of any other person or entity, by or through
any means including but not limited to social media: (i) solicit, invite, induce, cause, or encourage any director, officer, employee,
agent, representative, consultant, or contractor of the Company and its subsidiaries and affiliates to alter or terminate his, her, or
its employment, relationship, or affiliation with the Company and its subsidiaries and affiliates; (ii) interfere or attempt to interfere
with any aspect of the relationship between the Company and its subsidiaries and affiliates and any such director, officer, employee,
agent, representative, consultant, or contractor; or (iii) engage, hire, or employ, or cause to be engaged, hired, or employed, in any
capacity whatsoever, any such director, officer, employee, agent, representative, consultant, or contractor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Employee covenants and agrees that, during the Restricted Period, Employee shall not make any statement,
written or verbal, in any forum or media, or take any other action or engage in any conduct that disparages the Company and its subsidiaries
and affiliates, their services, products, officers, directors, managers, employees, shareholders, members, investments or agents. The
Company and its subsidiaries and affiliates covenant and agree that, during the Restricted Period, the Company and its subsidiaries and
affiliates shall not make any statement, written or verbal, in any forum or media, or take any other action or engage in any conduct that
disparages Employee. Nothing in this Section 4(d) shall prohibit any Person from (A) testifying truthfully in any legal or administrative
proceeding or otherwise truthfully responding to any other request for information or testimony to which such Person is legally required
to respond; (B) making any truthful statement to the extent necessary to rebut any untrue public statements made by another Person; (C)
making any statement or engaging in any conduct that would constitute a permitted disclosure; (D) making any truthful statement as part
of or in any arbitration or court proceeding that involves such Person; or (E) making any truthful statement or expression of opinion
in connection with requests from third parties for employment references or in connection with discussions involving matters of workplace
concern, such as performance review, bonus determination, or investigation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Employee represents, warrants, agrees,
and understands that: (i) the covenants and agreements set forth in this Section 4 of the Agreement are reasonable in their geographic
scope, temporal duration, and the type and scope of activities they restrict; (ii) the Company&rsquo;s agreement to employ Employee, and
a portion of the compensation to be paid to Employee hereunder, are in consideration for such covenants and Employee&rsquo;s continued
compliance therewith, and constitute adequate and sufficient consideration for such covenants; (iii) Employee shall not raise any issue
of, nor contest or dispute, the reasonableness of the geographic scope, temporal duration, or content of such covenants and agreements
in any proceeding to enforce such covenants and agreements; (iv) the enforcement of any remedy under this Agreement will not prevent Employee
from earning a livelihood, because Employee&rsquo;s past work history and abilities are such that Employee can reasonably expect to find
work in other areas and lines of business; (v) the covenants and agreements set forth in this Section 4 of the Agreement are essential
for the Company&rsquo;s and its subsidiaries and affiliates reasonable protection, are designed to protect the Company&rsquo;s and its
subsidiaries and affiliates legitimate business interests, and are necessary and implemented for legitimate business reasons; and (vi)
in entering into this Agreement, the Company has relied upon Employee&rsquo;s representation that he will comply in full with the covenants
and agreements set forth in this Section 4 of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If Employee breaches Section 4(a), 4(b),
or 4(c) above, then the period during which that section remains in effect shall be extended by the length of time during which such breach
continues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><B>CONFIDENTIALITY</B>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Confidential Information</I></B>. Employee acknowledges that during his employment with the Company,
and by the nature of Employee&rsquo;s duties and obligations hereunder, Employee will come into close contact with confidential information
of the Company and its subsidiaries, affiliates, and/or other related entities, as applicable, including but not limited to: trade secrets,
know-how, Intellectual Property (as that term is defined below), business plans, client/customer lists, pricing, sales and marketing information,
products, research, algorithms, market intelligence, services, technologies, concepts, methods, sources, methods of doing business, patterns,
processes, compounds, formulae, programs, devices, tools, compilations of information, development, manufacturing, purchasing, engineering,
computer programs (whether in source code or object code), theories, techniques, procedures, strategies, systems, designs, works of art,
the identity of and any information concerning affiliates or customers, or potential customers, information received from others that
the Company and its subsidiaries and affiliates are obligated to treat as confidential or proprietary, and any other technical, operating,
non-public financial, and other business information that has commercial value, whether relating to the Company, its business, potential
business, or operations, or the business of any of the Company&rsquo;s affiliates, subsidiaries, related entities, clients, customers,
suppliers, vendors, licensees, or licensors, that Employee may develop or of which Employee may acquire knowledge during his employment
with the Company, or from his colleagues while working for the Company, whether prior to, during, or subsequent to his execution of this
Agreement, and all other business affairs, methods, and information not readily available to the public (collectively, &ldquo;<I>Confidential
Information</I>&rdquo;). Confidential Information does not include: (i) Employee&rsquo;s general skills and experience; (ii) information
that was lawfully in Employee&rsquo;s possession prior to his employment with the Company (other than through breach by a third party
of any confidentiality obligation to the Company and its subsidiaries and affiliates); (iii) information that is or becomes publicly available
without any direct or indirect act or omission on Employee&rsquo;s part; (iv) information that is required to be disclosed pursuant to
any applicable law, regulation, judicial or administrative order or decree, or request by other regulatory organization having authority
pursuant to the law; provided, however, that, except as set forth in and subject to Section 5(b) of this Agreement, Employee shall first
have given reasonable notice to the Company prior to making such disclosure; or (v) information that is generally known within the industries
or trades in which the Company and its subsidiaries and affiliates transact business.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The term &ldquo;<I>Intellectual Property</I>&rdquo;
means all discoveries, procedures, designs, creations, developments, improvements, methods, techniques, practices, methodologies, data
models, databases, scripts, know-how, processes, algorithms, application program interfaces, software programs, software source documents
and training manuals, codes, formulae, works of authorship, mask-works, reports, memoranda, ideas, inventions, customer lists, business
and/or financial information, and contributions of any kind, whether or not they are patentable, registrable, or protectable under federal
or state patent, copyright, or trade secret laws, or similar statutes, or protectable under common-law principles, and regardless of their
form or state of development, that are made, conceived, generated, or reduced to practice by Employee, in whole or in part, either alone
or jointly with others, or while Employee was serving as an officer, director, employee, or consultant of, or in any other capacity with,
the Company. Notwithstanding anything else in this Agreement, and as it used in this Section 5, the term &ldquo;Intellectual Property&rdquo;
excludes any software program, application program interface, equipment, supplies, resources, facilities, data, products, information,
materials, or trade secrets used by the Company and its subsidiaries and affiliates, and which was developed entirely on Employee&rsquo;s
own time, unless said Intellectual Property: (i) relates to the Company&rsquo;s and its subsidiaries and affiliates business or potential
business; or (ii) results from tasks assigned to Employee by the Company or from work performed by Employee for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Employee acknowledges and agrees that
each and every part of the Company&rsquo;s and its subsidiaries and affiliates Confidential Information: (a) has been developed by the
Company and its subsidiaries and affiliates at significant effort and expense; (b) is sufficiently secret to derive economic value from
not being generally known to other parties; (c) is proprietary to and a trade secret of the Company and its subsidiaries and affiliates
and, as such, is a valuable, special, and unique asset of the Company and its subsidiaries and affiliates; and (d) constitutes a protectable
business interest of the Company and its subsidiaries and affiliates. Employee further acknowledges and agrees that any unauthorized use
or disclosure of any Confidential Information by Employee will cause irreparable harm and loss to the Company and its subsidiaries and
affiliates. Employee acknowledges and agrees that the Company and its subsidiaries and affiliates own the Confidential Information. Employee
agrees not to dispute, contest, or deny any such ownership rights either during or after Employee&rsquo;s employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In recognition of the foregoing, and except
as set forth in and subject to Section 5(b) of this Agreement, Employee covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)</FONT></TD><TD STYLE="text-align: justify">Employee will use Confidential Information only in the performance of his duties and obligations hereunder
for the Company. Employee will not use Confidential Information, directly or indirectly, at any time during or after his employment with
the Company, for his personal benefit, for the benefit of any other person or entity, or in any manner adverse to the interests of the
and its subsidiaries and affiliates. Further, Employee will keep secret all Confidential Information and will not make use of, divulge,
or otherwise disclose Confidential Information, directly or indirectly, to anyone outside of the Company, except with the Company&rsquo;s
prior written consent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">Employee will take all necessary and reasonable steps to protect Confidential Information from being disclosed
to anyone within the Company who does not have a need to know the information and to anyone outside of the Company, except with the Company&rsquo;s
prior written consent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify">Employee shall not at any time remove, copy, download, or transmit any information from the Company and
its subsidiaries and affiliates during the term of this Agreement, except for the benefit of the Company and in accordance with this Agreement
and the Company&rsquo;s policies; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)</FONT></TD><TD STYLE="text-align: justify">Promptly upon Employee&rsquo;s termination, and in any event no later than three (3) business days after
Employee&rsquo;s employment with the Company ceases, Employee shall return to the Company and its subsidiaries and affiliates any and
all Confidential Information in his possession, custody, or control, including but not limited to all memoranda, notes, records, plans,
reports, forecast, marketing information, financial records and information, employee or contractor records and files, client lists, training
materials, trade secrets, and all other documents (and all copies thereof), whether in electronic or hard copy form, which Employee obtained
while employed by the Company or otherwise serving or acting on behalf of the Company, or which Employee may then possess or have under
Employee&rsquo;s control.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Duration of Covenant</I></B>. Employee acknowledges and agrees that his obligations under this Section
5 of the Agreement shall remain in effect for the duration of Employee&rsquo;s employment relationship with the Company or its subsidiaries
or affiliates and for a period of five (5) years thereafter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Notwithstanding the foregoing, nothing
in this Agreement shall be construed as, or shall interfere with, abridge, limit, restrain, or restrict Employee&rsquo;s (or his attorney&rsquo;s)
right, without prior authorization from or notification to the Company: (i) to engage in any activity or conduct or any provision of the
National Labor Relations Act (and, in fact, this Section 5 of the Agreement shall not apply to, among other things, any discussion of
company wages, hours, and working conditions as protected by the National Labor Relations Act and/or any other applicable federal, state,
or local law); (ii) to communicate with any federal, state, or local government agency charged with the enforcement and/or investigation
of claims of discrimination, harassment, retaliation, improper wage payments, or any other unlawful employment practices under federal,
state, or local law, or to file a charge, claim, or complaint with, or participate in or cooperate with any investigation or proceeding
conducted by, any such agency; (iii) to report possible violations of federal, state, or local law or regulation to any government agency
or entity, including but not limited, to the extent applicable, to the U.S. Department of Labor, the Department of Justice, the Securities
and Exchange Commission (the &ldquo;<I>SEC</I>&rdquo;), the Congress, and/or any agency Inspector General, or make other disclosures that
are protected under the whistleblower provisions of federal, state, or local law or regulation; or (iv) to communicate directly with,
respond to any inquiry from, or provide testimony before, to the extent applicable, the SEC, the Financial Industry Regulatory Authority,
any other self-regulatory organization, or any other federal, state, or local regulatory authority, regarding this Agreement or its underlying
facts or circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In addition, Employee shall not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (i) in
confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the
purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit
or other proceeding, if such filing is made under seal. Further, in the event that Employee files a lawsuit for retaliation by the Company
for reporting a suspected violation of law, Employee may disclose the trade secret to his attorney and use the trade secret information
in the court proceeding, if Employee: (A) files any document containing the trade secret under seal; and (B) does not disclose the trade
secret, except pursuant to court order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">To the extent that this Agreement conflicts
with the federal Speak Out Act (Public Law No: 117-224), said act shall control and supersede the conflicting portion of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><B><I>Retention of All Other Rights</I></B>. Employee&rsquo;s obligations under this Section 5 of the
Agreement are in addition to, and not in place or lieu of, any other statutory or common law obligations that Employee may have with regard
to the maintenance, preservation, protection, use, and/or disclosure of Confidential Information, and the Company specifically reserves
all rights it may have against Employee should Employee violate any such statutory or common law obligations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><B>INJUNCTIVE RELIEF</B>. Employee agrees that it would be difficult to measure any damages caused to
the Company and its subsidiaries and affiliates which might result from any breach by Employee of the covenants and agreements set forth
in Sections 4 and 5 of this Agreement, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly,
and notwithstanding any other provision of this Agreement, Employee agrees that if Employee breaches, or the Company and its subsidiaries
and affiliates reasonably believe that Employee is likely to breach, Sections 4 or 5 of this Agreement, the Company and its subsidiaries
and affiliates shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable
relief to restrain any such breach, without showing or proving any actual damage to the Company and its subsidiaries and affiliates. Any
award or relief to the Company and its subsidiaries and affiliates may, in the discretion of the court, include the Company&rsquo;s and
its subsidiaries and affiliates costs and expenses of enforcement (including reasonable attorneys&rsquo; fees, court costs, and expenses).
Nothing contained in this Section 6 of the Agreement or in any other provision of the Agreement shall restrict or limit in any manner
the Company&rsquo;s and its subsidiaries and affiliates right to seek and obtain any form of relief, legal or equitable, and shall not
waive the Company&rsquo;s and its subsidiaries and affiliates right to any other relief related to any dispute arising out of this Agreement
or related to Employee&rsquo;s employment with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><B>NOTICES</B>. Any notice or other communication required or permitted to be given hereunder shall be
in writing and shall be deemed to have been given (i) when delivered personally or by hand (with written confirmation of receipt); (ii)
if sent by a nationally-recognized overnight courier, on the date received by the addressee (with written confirmation of receipt); or
(iii) on the date sent by electronic mail or facsimile (with confirmation of transmission), to the recipient(s) and address(es) specified
below (or to such other recipient and/or address as either Party may, from time to time, designate in writing in accordance with the terms
and conditions of this Agreement).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><B>LEGAL REPRESENTATION</B>. Employee acknowledges that he was advised to consult with, and has had ample
opportunity to receive the advice of, independent legal counsel before executing this Agreement &ndash; and the Company hereby advises
Employee to do so &ndash; and that Employee has fully exercised that opportunity to the extent he desired. Employee acknowledges that
he had ample opportunity to consider this Agreement and to receive an explanation from such legal counsel of the legal nature, effect,
ramifications, and consequences of this Agreement. Employee warrants that he has carefully read this Agreement, that he understands completely
its contents, that he understands the significance, nature, effect, and consequences of signing it, and that he has agreed to and signed
this Agreement knowingly and voluntarily of his own free will, act, and deed, and for full and sufficient consideration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><B>ENTIRE AGREEMENT; AMENDMENT</B>. This Agreement, together with all exhibits and schedules annexed hereto,
including but not limited to the Plan, constitutes the entire agreement between the Parties relating to the subject matter hereof, and
supersedes all prior agreements and understandings, whether oral or written, with respect to the same. In entering into and performing
under this Agreement, neither the Company nor Employee has relied upon any promises, representations, or statements except as expressly
set forth herein. No modification, alteration, amendment, revision of, or supplement to this Agreement shall be valid or effective unless
the same is memorialized in a writing signed by both by Employee and a duly-authorized representative or agent of the Company. Neither
e-mail correspondence, text messages, nor any other electronic communications constitutes a writing for purposes of this Section 10 of
the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><B>GOVERNING LAW</B>. This Agreement shall in all respects be interpreted, enforced, and governed by and
in accordance with the internal substantive laws (and not the laws of choice of laws) of the State of Delaware.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><B>ASSIGNMENT</B>. This Agreement shall not be assignable by Employee, but shall be binding upon Employee
and upon his heirs, administrators, representatives, executors, and successors. This Agreement shall be freely assignable by the Company
without restriction and, without limitation of the foregoing, shall be deemed automatically assigned by the Company with Employee&rsquo;s
consent in the event of any sale, merger, share exchange, consolidation, or other business reorganization. This Agreement shall inure
to the benefit of the Company and its successors and assigns.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify"><B>SEVERABILITY</B>. If one or more of the provisions of this Agreement is deemed void by law, then the
remaining provisions shall continue with full force and effect and, if legally permitted, such offending provision or provisions shall
be replaced with an enforceable provision or enforceable provisions that as nearly as possible effects the Parties&rsquo; intent. Without
limiting the generality of the foregoing, the Parties hereby expressly state their intent that, to the extent any provision of this Agreement
is deemed unenforceable due to the scope, whether geographic, temporal, or otherwise, being deemed excessive, unreasonable, and/or overbroad,
the court, person, or entity rendering such opinion regarding the scope shall modify such provision(s), or shall direct or permit the
Parties to modify such provision(s), to the minimum extent necessary to cause such provision(s) to be enforceable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify"><B>SURVIVAL</B>. Upon the termination or expiration of this Agreement, the entire Agreement shall survive
such termination or expiration, and shall continue, with full force and effect, in accordance with their respective terms and conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify"><B>WAIVER</B>. The failure of either Party to insist, in any one or more instances, upon the performance
of any of the terms, covenants, or conditions of this Agreement or to exercise any right hereunder, shall not be construed as a waiver
or relinquishment of the future performance of any rights, and the obligations of the Party with respect to such future performance shall
continue with full force and effect. No waiver of any such right will have effect unless given in a writing signed by the Party against
whom the waiver is to be enforced.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify"><B>COMPLIANCE WITH SECTION 409A OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (&ldquo;SECTION 409A&rdquo;).</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">It is the intention of the Parties that all payments and benefits under this Agreement (and any amendment
hereto) shall be made and provided in a manner that is either exempt from or compliant with Section 409A of the Internal Revenue Code
and the rules, regulations and notices thereunder (&ldquo;<I>Code Section 409A</I>&rdquo;). Any ambiguity in this Agreement (or any amendment
hereto) shall be interpreted to comply with the above. Employee acknowledges that the Company has made no representations and makes no
guarantee as to the treatment of the compensation and benefits provided hereunder and Employee has been advised to obtain his own tax
advice, and further, Employees agrees that the Company and the Company&rsquo;s officers, employees, agents, equity holders, successors,
affiliates and representatives shall have no liability for any of the payments or benefits under this Agreement or any other arrangement
failing to be exempt from or to comply with Code Section 409A. Each amount or benefit payable pursuant to this Agreement (and any amendment
hereto) shall be a separate payment for purposes of Code Section 409A. For all purposes of this Agreement, any iteration of the word &ldquo;termination&rdquo;
(e.g., &ldquo;terminated&rdquo;) with respect to Employee&rsquo;s employment shall mean a separation from service within the meaning of
Code Section 409A. Without limiting the generality of the foregoing, for purposes of this Agreement, Employee shall be considered to have
a termination of employment only if such termination is a &ldquo;separation from service&rdquo; within the meaning of Code Section 409A.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">To the extent that the reimbursement of any benefits or the provision of any in-kind kind benefits pursuant
to this Agreement is subject to Code Section 409A: (a) the amount of such expenses eligible for reimbursement, or in-kind benefits to
be provided hereunder during any calendar year shall not affect the amount of such expenses eligible for reimbursement or in-kind benefits
to be provided hereunder in any other calendar year; (b) all such expenses eligible for reimbursement hereunder shall be paid to the Employee
no later than December 31<SUP>st</SUP> of the calendar year following the calendar year in which such expenses were incurred; and (c)
Employee&rsquo;s right to receive any such reimbursements or in-kind benefits shall not be subject to liquidation or exchange for any
other benefits.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Notwithstanding anything in this Agreement to the contrary, in the event the stock of the Company (or
its successor) is publicly traded on an establishes securities market or otherwise and the Employee is a &ldquo;specified employee&rdquo;
(as determined under the Company&rsquo;s administrative procedure for such determinations, in accordance with Code Section 409A) at the
time of Employee&rsquo;s termination of employment, any payments under this Agreement that are deemed to be deferred compensation subject
to Code Section 409A and payable in connection with a separation from service shall not be paid or begin payment until the earlier of
(a) Employee&rsquo;s death or (b) the first day following the six (6) month anniversary of the Termination Date. If the payment of any
amounts under this Agreement are delayed as a result of the previous sentence, on the first day following the end of the six (6) month
period, the Company shall pay Employee a lump sum amount equal to the cumulative amounts that would have otherwise been previously paid
to Employee under this Agreement during such six (6) month period, without interest thereon. To the extent permitted under Code Section
409A, any separate payment or benefits under this Agreement or otherwise shall not be &ldquo;deferred compensation&rdquo; subject to Code
Section 409A and the six-month delay provided in this subsection, to the extent provided in the exceptions in Treasury Regulation Section
1.409A-1(b)(4) and (b)(9) and any other applicable exception or provision under Code Section 409A.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify"><B>TAXES</B>. The Parties acknowledge and agree that the Company may withhold from any amounts payable
under this Agreement such federal, state, local, and foreign taxes and withholdings as may be required to be withheld pursuant to any
applicable law, rule, or regulation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify"><B>SECTION HEADINGS</B>. The section headings used in this Agreement are included solely for convenience,
and shall not affect, or be used in connection with, the interpretation of this Agreement. Any reference to any gender in this Agreement
shall include, where appropriate, any other gender.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.</TD><TD STYLE="text-align: justify"><B>COUNTERPARTS</B>. This Agreement may be executed in one or more counterparts, each of which will be
deemed to be an original copy of this Agreement and all of which, when taken together, will be deemed to constitute one and the same agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Parties have executed
this Agreement as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 40%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMPANY</B>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps">Kindly MD, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 4%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%; layout-grid-mode: line">/s/ Amanda Fabiano</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amanda Fabiano</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Operating Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 40%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EMPLOYEE</B>:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;/s/ John Dalton</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">John Dalton</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Employment Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Description of the Duties and Responsibilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employee shall provide to the Company the following duties and responsibilities
(including, as applicable, preparatory work and revisions), which may be amended from time to time by the Company:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Timely
and accurate financial reporting in accordance with U.S. GAAP and Company requirements.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compliance with SEC, exchange, and regulatory filing obligations, including
supporting the timely preparation of all required reports.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Maintenance of effective internal controls and adherence to Sarbanes-Oxley
requirements, including prompt escalation and remediation of issues.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cooperation with internal and external auditors, providing complete and accurate
information within reasonable timelines.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adherence to Company policies, governance procedures, and ethical standards,
including confidentiality and integrity in all financial matters.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective communication with the CEO, CFO, other executives, and Board committees,
including timely reporting of material issues.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Leadership and oversight of the accounting function, ensuring staffing, processes,
and systems are sufficient to meet the Company&rsquo;s financial and compliance obligations.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professional diligence and application of best practices to protect the Company&rsquo;s
financial integrity and reputation.</FONT></TD></TR></TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea026878901ex99-1_kindlymd.htm
<DESCRIPTION>PRESS RELEASE, DATED DECEMBER 8, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>KindlyMD Strengthens Leadership Team with Senior
Finance Talent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Former Jefferies Financial Group Executives
Teri Gendron and John Dalton Join as Chief Financial Officer and Chief Accounting Officer &amp; Controller, Respectively</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Salt Lake City, UT &ndash; December 8, 2025</B>:
KindlyMD, Inc. (NASDAQ: NAKA) (&ldquo;KindlyMD&rdquo; or the &ldquo;Company&rdquo;), a provider of integrated healthcare services and
a Bitcoin treasury company via its subsidiary Nakamoto Holdings, Inc. (&ldquo;Nakamoto&rdquo;), today announced the appointments of Teri
Gendron, former Chief Financial Officer of Markel Corporation, and Jefferies Financial Group, as Chief Financial Officer and Treasurer,
and John Dalton, former Chief Financial Officer of Jefferies Finance LLC, as Chief Accounting Officer and Controller, effective immediately.
Together, they bring decades of public company finance, accounting, and capital markets leadership, providing the depth and discipline
required to support KindlyMD&rsquo;s long-term growth and execution of the Company&rsquo;s differentiated Bitcoin treasury strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Adding leaders of Teri and John&rsquo;s
caliber reflects the standard we are setting as we continue building a unified Bitcoin operating company,&rdquo; said David Bailey, Chairman
and CEO of KindlyMD. &ldquo;Achieving our mission requires precision, discipline, and financial stewardship. Strengthening our finance
capabilities with proven public company executives is a critical step in that plan, and Teri and John&rsquo;s leadership will anchor the
financial and operational foundation required to scale responsibly and deliver durable value for shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;KindlyMD and Nakamoto are assembling a
strategy with the scale and ambition to redefine what a modern finance organization looks like,&rdquo; said Ms. Gendron. &ldquo;I look
forward to partnering with David and the team to strengthen our financial infrastructure and help ensure the Company scales with the discipline
and operational excellence required for its next phase of growth.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Dalton added, &ldquo;Joining KindlyMD presents a rare opportunity
to help build the financial architecture of a company with a truly compelling story to tell. Robust reporting, rigorous controls, and
high-quality disclosure are the foundation of any high-performing public company, and I look forward to enhancing our systems to ensure
we meet the highest standards of accuracy, transparency, and accountability as we scale.&rdquo;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Teri Gendron Bio</U></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ms. Gendron brings extensive experience leading large, complex finance
organizations through transformative transactions, capital markets activity, and multi-business integrations. She most recently served
as Chief Financial Officer of Markel Group Inc., where she oversaw all aspects of the holding company&rsquo;s financial operations, including
reporting, accounting, tax and treasury. Prior to that, she spent nearly a decade at Jefferies Financial Group Inc., serving as Vice President
and Chief Financial Officer from 2014 to 2023. From 2011 to 2014, she was Vice President and Controller of Gannett Co., Inc., where she
also served as Chief Accounting Officer. Earlier in her career, Ms. Gendron held the role of Vice President and Controller at NII Holdings,
Inc., a global mobile communications provider, after joining the company as Finance Director in 1998. Ms. Gendron currently serves on
the Board, and is a member of the Audit Committee of Hillman Solutions Corp, which she joined at the time they became publicly traded
in 2021. She is NACD Directorship Certified and a Certified Public Accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>John Dalton Bio</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Dalton previously served as the Chief Financial
Officer of Jefferies Finance LLC, where he oversaw all financial operations including accounting, consolidation, and financial reporting
functions for a leading loan arranger, investor and asset manager. Before that, he was Vice President, Controller, and Chief Accounting
Officer of Jefferies Financial Group Inc., managing consolidation, external reporting, technical accounting, and acquisition integration.
Earlier in his career, Mr. Dalton spent more than a decade at Gannett Co. Inc., holding roles of increasing responsibility across consolidation,
reporting, technical accounting, and internal audit. He is a Certified Public Accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About KindlyMD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">KindlyMD&reg; is a patient-first and healthcare data company redefining
value-based care and patient-centered medical services. Formed in 2019, KindlyMD leverages data analysis to deliver evidence-based, personalized
solutions in order to reduce opioid use, improve health outcomes faster, and provide value based, algorithmic guidance on the use of alternative
medicine in healthcare. In August 2025, KindlyMD completed its merger with Nakamoto Holdings Inc., a Bitcoin-native holding company. This
strategic partnership formed a public Bitcoin strategy that unites KindlyMD&rsquo;s healthcare expertise with Nakamoto&rsquo;s vision
of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury
management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&zwj;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Nakamoto</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nakamoto is a Bitcoin company building a global portfolio of Bitcoin-native
companies. Nakamoto plans to grow its Bitcoin holdings through disciplined accumulation and to leverage its treasury to acquire and develop
an ecosystem of Bitcoin companies across finance, media, advisory and more. Nakamoto aims to provide commercial and financial infrastructure
for the next generation of capital markets. For more information, please visit nakamoto.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All statements, other than statements of historical fact, included
in this press release that address activities, events or developments that that the Company expects, believes or anticipates will or may
occur in the future are forward-looking statements, as defined under U.S. federal securities laws, related to the Company. Forward-looking
statements can be identified by the fact that they do not relate strictly to historical or current facts and often include statements
about our future operations, business strategies, plans, objectives, expectations, intentions, goals, projections, prospects, future events,
or performance, as well as underlying assumptions. These statements covering matters such as expectations, plans, strategic outlooks,
financial projections, market conditions, regulatory environments, Bitcoin-related strategies, Bitcoin treasury management activities,
and the Company&rsquo;s anticipated holding of Bitcoin as part of its corporate treasury are inherently uncertain and involve numerous
assumptions and risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking terms used may include, but are not limited to, &ldquo;estimate,&rdquo;
&ldquo;project,&rdquo; &ldquo;predict,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;potential,&rdquo;
&ldquo;create,&rdquo; &ldquo;intend,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;will,&rdquo;
&ldquo;guidance,&rdquo; &ldquo;look,&rdquo; &ldquo;goal,&rdquo; &ldquo;future,&rdquo; &ldquo;build,&rdquo; &ldquo;focus,&rdquo; &ldquo;continue,&rdquo;
&ldquo;strive,&rdquo; &ldquo;allow,&rdquo; &ldquo;seek,&rdquo; &ldquo;aim,&rdquo; &ldquo;target,&rdquo; or the negative of such terms
or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions,
or events identify forward-looking statements and similar expressions. However, the absence of these words does not mean that the statements
are not forward-looking. These forward-looking statements include, but are not limited to, descriptions of the Company and its operations,
strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, including
the purchase, custody, and potential sale or other use of Bitcoin, synergies, opportunities and anticipated future performance, including
the management team and board of directors of the Company. These statements may also relate to broader macroeconomic trends, industry
developments, technology adoption, competitive positioning, market expansion, product launches, research and development efforts, acquisitions
or dispositions, legal or regulatory developments, and other initiatives that could affect our future business performance. There are
a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included
in this communication. These include risks relating to Bitcoin market volatility, cybersecurity and custody of digital assets, potential
changes in laws or accounting standards relating to cryptocurrency, and regulatory developments affecting Bitcoin or other digital assets,
as well as the risk that changes in the Company&rsquo;s capital structure and governance could have adverse effects on the market value
of its securities; the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their
suppliers and customers and on the Company operating results and business generally; the risk that the Company may be unable to reduce
expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations
or enforcement practices; adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting
standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior;
and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult
to predict and are beyond the Company&rsquo;s control, including those detailed in the Company&rsquo;s Annual Reports on Form 10-K, Quarterly
Reports on Form 10- Q, Current Reports on Form 8-K, and such other documents of the Company filed, or to be filed, with the SEC that are
or will be available on the Company&rsquo;s website at www.kindlymd.com and on the website of the SEC at www.sec.gov . All forward-looking
statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Any forward-looking
statement speaks only as of the date on which such statement is made, and the Company does not undertake any obligation to correct or
update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable
law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Nothing
contained herein constitutes an offer to buy or sell securities of the Company or any other party, nor does it constitute a solicitation
of any proxy or vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>Carissa Felger / Sam Cohen<BR>
Gasthalter &amp; Co.<BR>
(212) 257-4170<BR>
Nakamoto@gasthalter.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>Sean Mansouri, CFA / Aaron D&rsquo;Souza<BR>
Elevate IR<BR>
(720) 330-2829<BR>
NAKA@elevate-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>nakaw-20251208.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaaMGaPtyJ1xaYkxuG9/fZkaDyUrbBrKCyXqWu3msToO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:NAKAW="http://kindlymd.com/20251208" elementFormDefault="qualified" targetNamespace="http://kindlymd.com/20251208">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://kindlymd.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="nakaw-20251208_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="nakaw-20251208_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="nakaw-20251208_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="NAKAW_CommonStockParValue0.001Member" name="CommonStockParValue0.001Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" name="TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>nakaw-20251208_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="nakaw-20251208.xsd#Cover" roleURI="http://kindlymd.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kindlymd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_CommonStockParValue0.001Member" xlink:label="loc_NAKAWCommonStockParValue0.001Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NAKAWCommonStockParValue0.001Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" xlink:label="loc_NAKAWTradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NAKAWTradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>nakaw-20251208_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_CommonStockParValue0.001Member" xlink:label="NAKAW_CommonStockParValue0.001Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NAKAW_CommonStockParValue0.001Member" xlink:to="NAKAW_CommonStockParValue0.001Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NAKAW_CommonStockParValue0.001Member_lbl" xml:lang="en-US">Common Stock, par value $0.001</link:label>
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" xlink:label="NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" xlink:to="NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember_lbl" xml:lang="en-US">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>nakaw-20251208_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="nakaw-20251208.xsd#Cover" roleURI="http://kindlymd.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://kindlymd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_CommonStockParValue0.001Member" xlink:label="loc_NAKAWCommonStockParValue0.001Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NAKAWCommonStockParValue0.001Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="nakaw-20251208.xsd#NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" xlink:label="loc_NAKAWTradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NAKAWTradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  08,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kindly MD, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001946573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-3829824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5097 South 900 East<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">388-8220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NAKAW_CommonStockParValue0.001Member', window );">Common Stock, par value $0.001</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAKA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember', window );">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAKAW<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NAKAW_CommonStockParValue0.001Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NAKAW_CommonStockParValue0.001Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0268789-8k_kindlymd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kindlymd.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0268789-8k_kindlymd.htm">ea0268789-8k_kindlymd.htm</File>
    <File>nakaw-20251208.xsd</File>
    <File>nakaw-20251208_def.xml</File>
    <File>nakaw-20251208_lab.xml</File>
    <File>nakaw-20251208_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0268789-8k_kindlymd.htm": {
   "nsprefix": "NAKAW",
   "nsuri": "http://kindlymd.com/20251208",
   "dts": {
    "inline": {
     "local": [
      "ea0268789-8k_kindlymd.htm"
     ]
    },
    "schema": {
     "local": [
      "nakaw-20251208.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "nakaw-20251208_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "nakaw-20251208_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nakaw-20251208_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://kindlymd.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0268789-8k_kindlymd.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0268789-8k_kindlymd.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "auth_ref": []
    },
    "NAKAW_CommonStockParValue0.001Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kindlymd.com/20251208",
     "localname": "CommonStockParValue0.001Member",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "NAKAW_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kindlymd.com/20251208",
     "localname": "TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://kindlymd.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-25-118971-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-118971-xbrl.zip
M4$L#!!0    ( #I!B%M[150V01X  $NH   9    96$P,C8X-S@Y+3AK7VMI
M;F1L>6UD+FAT;>T]:7?:QMK?]2OFI;>W]BD[>,%V? \&[!(O.(#C)%]\!C2
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M(X7?6+"0>:6=8G%_J?E>7NJ*E?_GBTH4O$"',,#$\;GKHY"#FN"R,RGFMY3
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M>PRP1%;/[R[.[\3I?I@F( G4U>FW);(@S0(YI_R6>>3LK/(\CF T,#SVH]U
M[<7<P+.=&+SY?C8>%<Y')XU1<^=)$O5\1SVC K:[VKE,IR7!O)@B.&IFHJX,
M@"ADM1<B#AX9Q<:_NLU:9J^>V1\]HP3F<H/WI9W<YV^MGU,"2VN\W/6O+C*-
M=H5<&E9@A5]SM\FTJ/(:B\!U2\?2"B.=">F*!6'H=0N^@GD#54V9K=9JADN
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MK!Z 19*N[8C,:BKOU/,PN]>ESL"#BO(0ZH-IR'=U<VY8*TJEH%CO:A'%0%T
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M#R6G,AU;G^#/@3<T#_\?4$L#!!0    ( #I!B%MV/\YM7$4  +AZ 0 >
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M0H(ZV(+AH%G 5YTQ*@V<EZT(8G7K*'$G/)E=9.I$F<C%^!ULKN5Z@NQKH9;
M7.6H"C!P-%@@L.&6;=)N G79Y5@&BHK-8@%LCUZ0J>O8HR^V('%F>C)ARRRB
MZ]"WB>8QG%W+0+QT7PT'1_""P,S:,MMOR&R3VS#;HX;L5*2]][I:(*,;I5EJ
M['#FN4=-B??_-JPW]C@<7WQD5? ?9%75\V@GW27J]]T"2&X\%> =24J\?YVI
M_0+> J\1M8<?5&4)_!48%>DW96M)<)436C#; ZH!KEBFO -5<%^1*R=PG<;
MDEB'!QJ/C:X3(:?#"UWA-Y%_+SM*#TL/T(_,+K6W$>XU&C:Q*$:&32+7A0\-
MT\TUJ'*5*M.,U"7'@^-5RA[LE^<"/,"C)"Y=%[1QWL[A"WA?P/()=A&_:6^B
MK%I4-?B!77M+_Y.O1[QA7?)1],8EJW"@L %E7N/,D?N/FBK-8<%[6?I!K#>-
MIE**VPAW+@>1BBR5?#=-N2@J8F$JN4)S331@\Q)VD)%WK*HM Y1IXF9<[<(A
M7Q7 !JO&CD(:*VQ(C4>7HC2%&<#\>#;5!]11O)-WBGY1$>WR:2N18'8NG=&O
MPIM A#D"AM_:3D<N1J>-032H,4IPH6>0%&.=@$BLHAVGJI,4A=."W2)]_SJ%
MO2(QF\*G77H-A]U]0:_>N6I=6"!2, W4-0Q=-AG.H-33)K.6 CP#LP3AAH<A
MLHF=9W)WZIFJ[12=O$*"O@VC^2:RYLZ=R3>,=I*SR+XBNIP9K0_XY4ZU:S26
MX<#IC<!S)K"CL-M\6/YO\5%M/2%P4*.B^!"SI;1T-!6+[L$4!3>K6-1,17,%
M=PG^7Z.JZQ306"AG. C\NZU9>LJMT<[SNBPROE0-L*1*)YK9MUD%W6=^S<.O
ML^5;94*4"7T;9>*T@%LIA->UV-!S!JQ)BT,]N@8I0]YU(N@*2 6H T7=J&AR
M4F/1:&A&?X 01N8$%#4<7(.X!GY,S*Q46:2<H;)0**R-TY[(%]X#]%3#:$A"
MPEZ70-7Z*BV:"G\"-#9NRA+I42Y%R:(=[32RW-"]0K2,UD?19(F8*B :C.V"
M<J5,QSQHV\)!Z08ONU;+'LXF,A#79Z1QYS>)T]&*$6P\\UB2Y;3 A\.!4S^:
MDB:]=J]):/)HY#3I$\XW#2JW%\\+]C(CV^)S#Z@5L[*+(I%XVW,#.8D'Y]'?
M1GN#=(@V)JT,C65B;R5&WRH]!NTIEM$G*?(&] PSGP2+6M<*]*8TIXUEE:&8
MH$JU[-WB&Y93.3%YC6;;R/#<3*N2_A &W:#5E[".3ML$G*-(6@Y&,OC)A Q'
MZU5)UVOV*<70<K&8;_V"".>1YG="A5]4^G]N6.W;3,(._Q][>]&;5&?)\^A<
M3?4+& .,%]AIF$JTMR<8A9=')[^%8 "6-?M/>H3-C_C9J"AAY^UGKS,U_A#M
M/WP&DZU ATA@"EUX 4HIMSTO'\&H/1,8E5I]V!MIH F8Y8)F[4_JQYXYX41O
M.Z2W-8]P;W@[[@O=_!7"L4\V#L<>GKT[/SZ].+@\.3N-#DZ/HM?'I\=O3BXO
M6'NX< K 2A\!< [QWU5 VOAECQN/3=L.AT'U,\W13;F6Y[$%V<(.& /4&M^(
MN]#68><)RY$7B@0FO"YRN5#+T%23USDY9F?': )D^ZL=B<F-OAN0V:WE/M_Z
M[_XL,?&#/$>HRH7*0/7HCXVSHH9DY12J:*2 LBIZ*@*QH,B5\9]/GSV.'S]^
MC&(Y6H*6@6X$D-7.3D]P^#ZO01O+TYF7\0VC^H(>&<_B5Q]Q\Y$(9T6&BJ#X
M#^ *-6/G3Q!%BD.6]JO0C\ .O7^Q%]P%_WNFVQ,V].8TT7C)LS@"W;1F_Q-&
M1C$4RFX/WN)@E2[T89SW/6/T.'0BTG]5F>!S8 EGSJW3\NI0 !9>RJ[[X:"S
M+$_9!:&<%]>9!ON$7^-4;=FSU8ZK4'/LZ&]IU1,1TQ_AD3J68R8$!=L:P+#Q
MB038$?H,F1_BZ]ZHM(S>*E GH@O9 6#78PYZ>6=!1Q"9W8]H\P]P31&/:9T9
MSKPREJ2&.Y/".TCO+?588[BCH/LZIV/ZM_ >G18UGJ$ULUATE'I:P+_XXC(A
M#P="R38F?Y7JZPT"^XR:$UR"$]C-XAK)ND"(P75.?S,',9'%_NM0X($E:876
M%AE1R*R <C (IV121@4(D7Q7JB2#:@+WIT #:FWPLGL!/&N$;WP@J^WOD(+P
MJD\L.,A[\H65_^(SD&6.E;BH^S>CR+-E\%.V1M$-9GX/E\H^ /0O#H9>E0:M
M6[*&\1K!:A=-634J9S^*X?NE8:(XXVFIYI'BF"#:D5DF[A<D&P:E\(<3WA-S
MZ=H.;7%XP]R30O,M5,D5>O7P!?1^=TUI-J#YP 4OX3;7XM[,A<M7<%8P4W@0
M&%.C:JND:0)T;!V!7T\K>?GF[/32G_3>1,'A+)_?A%@G<!4^W!E@C59SDB->
M')GUH:?8]K@4R5,#3,<P^LCC\XJ%<VK?Y2O)HO0JT#[*J:Z=#K3_R2M]]E@6
M^AU>B5 UZ-$$/)8Q',PU^@]!*X?;-LK2:N:8[NM">"AQ!E_/1UP+.MLLN)!^
M2GP5-7^"27$T"?YL0(8ZGMH.Y]L-9^>]O^-.<>/X)++Y*UP320'2$F';Z+_D
M3?."F+XMQ(XG1K%?*;C6<EKF* F:39X%E$V>1Y-MJKX#[J>2@->1"6BP'4^
M%CT=80XT!^_":(:Q D%V9#8X@B<0VFKUK&08WLR!)D")("U) BL,)27_W(KY
ML>:X8NYVWSPI*M[,,4P7R*Y<B@W,^Q*$>W$"0&0<L"6IIUC.V)"+$0FL62TR
M8+5),6[PNRUHXT_)7L>?P%Z%-YU[ZLX!$HICL)[7!9$:0#-PC]'5/=F4)PT'
M(5/J\@50W5&RXXT"_8>@'*A+X@5D>#3K=$"B;2IN,2^:>]2?.4-V(Z,=UKF/
M2 <.7Q.WI(P3*T:R3#%LX %O<2/W6%<U 2'X$V[M^ .8/<"2'PX'>/<%Y2O/
M.\"<RL880&?63UDM>(7_<Q]-<C++12*,LX*BZAB5P/\N8"3=5L/P()"AT.@.
M]25L:SC@P3MB@&>VCD!<+@T0244NY;IG!_P]HM'[M\2@@V#]_!PR<&_8&P7C
M#D;<ZFH%%3JI)>]9+;TZ.5"K-J'ZYE"WKVU LL!:3QK.0U,YLEBYA6%F6"<1
M;.V6RXVAQ+ KPA8!+P9-;E(T9;3S=%=.DZ-@ H'-"_HIWA9QB)(1G);P>'VM
M,[C7._M/=B.X,F H>XY5_!E?%;HY+1)Y?_%K=)BEDPDN$48+]27:$13>6DW0
MP(&!\GJY-T$N K,;$RM[\NR[77,YF<_Q\FAE9/(2ZD;[R6KM86/GHV%]!F=>
M$5J$AZ/=X/'^AN.9O4!?$BF^\#\E3)%,4+AI6290G2OQU7AG"DH0L,2='WB?
M@: \564C[WK7WXSSF!9%$GDN"M:TZ) ]C<4>(GGE"D%6(TNN/(\Y>8R -:03
M01WN1FQ8=PAK.##J#^MF7^M&?=W[NTE(\,F+Z&Q!\O Y#BHZ\XOH-Y4U^/77
MBACR#N1X2ME&&]'-,MY0F=L+XH!F)UY$E\L%+/B@5*-T_"(Z57/-NW5:X!X\
M"8*'YBG\)MK[=PEPWA>ZONR[TI4P4)55A6=)D0N8F.QXE@)K-$9;H&RD&?"7
M(M>AOH%A/F)$+ A(:;B-#O(P.L:GSWV#_\!C]3WF7K2!M<>Z]SIKSV!/S\'.
M^XNR-E^?#M1RXQE*JZIIYTZ -I"1RY%$!WDS\\0(UQR& <V@&CNQN/4UWN,,
MAM<<Z28B[T,=VCN&_I8Z8U<40L-2S,:LM7&<D*<,?CG7"2X%%:&FQ,L:H[%4
M-(MHIC$1,T8WFH'MN1]%H(]I_]_6[P@:DKKBJ"8ZWTJQ+@G31'==8O7DCL&8
M!7F2C.&";G[RFDWA5R7GA@8.-.LDW^LZR=M&X0Z#;"VO8:\:+\7':,>P61B)
M9"QQF<(=2)4_96)*DBP0&-+D_Z*%L (LJP@F(2@]-9G R'@"!E!L &ST$D+E
M36D^NZ%/TP\-@3V'$'TO"P[1[C:-C'P4)ODI4%77>0/<(MJQR'9<.(A*#@<7
M[L$@C2,Z^E[-%R_.''T(H"31\SR=I)Q@VQ\O5G7H1*7]/]RK&CB5(!RR]=[]
M.5#2OZFQP^E<I* *O]7J2F_*NJ[\QRM\/,/'0^+IVEC6)$-]01+_5KW*)9CX
M>(-NV'=+=-^2Z":W(;IC3I??6$"6.IV/FK)B19*25\D'*EG_-O_>H:81TSN&
M)_K@P7<"]8U^75"HFJ#;-"T/XT.>X@7#L($SLVCRDKD",Y_H.M$L&*A@TDH@
M0B!LNJGE=IL\E+GL%0J1X<!NTX98(/E]:_]-;LXWO(Y;4.N#5S]L7F/HS9OC
MP\OH[$UT>?S^W<DIH5MO+F @$!JKL721-T!<AY3#3\@\ ZH:Z:RXWO43_0]-
MHO\(-3O.7S6059>&3D%7EUGFQS"]W.^XS2L(J^(Q#&M;6[_I%D'ZIT&0>IG\
M82T;HI4#H(?W4DSBO4='0I<.8@F_]=\4TNUP8 G7":"3]64;TLJ_!^W"%N&W
M*V^)5VE#KD$EL$D$!NAPK?[[X76DCT\:9.6PI@HQ99X/OH,)\V26P3B&A33"
M2T05?D*)R_%%BK?F2T\Y&X^IC 8BV)J\H>":M>S\/3_JLW':\S2Z':;K*BI2
M,AS8H19*H.X4C<59A# 6 3;P3!8J73>33I16EG'F-NJ;!]*V'.-3*F"MON>A
M^"&FL(9IT*7[&>,^S&$L:Q@.;L4;ULU!1."J(7NC5P9_@%<#+P-B&$M]57P@
M_X1QQ,!'8"T)IA/SF#.5HC=AJC"$ULJ8HR)SHRI-4E6Z\A.<%PB_3$O?++..
M$=8:<<YS$K$M/%6KYD3@Y_&#E#S/3BU/DOL?%ZF#SY)7QCD[<,V&,7!*(6[M
M<"!3-1Q&WD]?IJ1AF"#GSM-GNU&BEK K% #M'&D_S\A4A>%6LSEP%3ZF\V;N
MY36BMHNA5<EE-3,8JYS4$CH^PB DY.LM\BFE?>)R1EDG5\$\?AC B8_=UK3J
MV\1V^T D$&PZ$3^B<W:9=P*EH@A9>N5V;CFK8_M@N\S.&BEET3>?*Z:Z=B%+
MJ5#;$Z$5J7G1Y!Z8LDH_#@<[/]JX.D\JWS/)IX%TB=>*M39^"(1/[.+7]/YV
M]'I3CXBYT)WT"R^NSE ![_4FUPN%(-<5D]^8MQ!-A$ "2P-",2:<+R?=$I@7
M&F'F:"V>"\;P4 J9T3^ZU&#SV]E_R0]5?N+Z#+T[+DX^TCK' F2)#MF)/^FT
M[-Y2E/]<0*S% D):[=FB]6OB2E)2UF<%0I(4-1D=(W'D+_?T$F362UW3J+;.
M#7K[,4 T'L-$0WY']-CD5US!D)!)<'DX$LX(@GS)_'(UF&6-$M3>?!G' Z'
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M19;03YP7-/8KXT=<^C7P7\O9D33%0FBI&J5D)1MPO?%.F/N#^+^UUR>L^($
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MMK>"F&UKE)Y5:LQJBI#PWFGFZ&JFBO6NF07M6K[-XV^SY!LK0*P =1,KX+C
M>!<+7M?5PA@7J",E0?+H$LX/BIB30(.D@'#@238LFIS,3S3VF^&O<'BB.@*!
MVMZZA&,6M"ZIKS+)HL0Y&/,$#UD3AR?IA?N .-7P,)0@4:A7(-1JH8NFPJ^
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MDHODO^,$.PN_\D19L5K2VLD@ 6!!3&Z?IC-N\E%@4XH5S+RDZ(\$^4U$&[(
MTU8M^&.=D\C&TCW$/2Q:_BQG^$93?(]FTU@5X'0;O">5AB8M?)&\)$U(-U,W
M?BM!MEUTUEO-VXM =)T$4.[Y-B*P<L#2<9"6(NB["LHF:N;$)Y-[%$K/_K9+
MF1.*NS2U)1$:90GWT:H4&$<6:"+L:',N$9GHBGO=,X+6T*8\>VZTQKF[>/!%
MW(%]3OP\^_Z[%P2?DM99;QZN!?)0J4]>;#+H[0SZBTT&?6-NWU&1SU<TMT%#
M]MC;8NGT&:IQIS"OR.G)J-:'"@8XIM2Z^V7L]W=JG92QM $S3''44E,AZX;%
M3KD.F!YXJBK(E"*8-]<Z5(00(U[SA:[96FW0<!C9PB?8@$53HI2CO9"A\^QS
M@^ L8@3L<I<O.)#M25AZ+:9[B._6.L#IP,HT&=Y,H89/JAI$C^-/X!6G:#)S
M(T6ES$]%Z6$5VNO')3>]TG"S+JS3)/6M%7_"ZYW]B-<,K)5>P^B20&_V,3>U
MP+'#EKQHG*(S8@C?7YC/B Z&V%UP/:[I6!Q'X/5*CW@OYFA KUC-8!PIJ>9N
M?1&7#MTAQ)'T[L2NQ- "M=;"A7?6FV1THSG2&P)]TS>!5'-%'958+!,"6UUR
MC9:1-(+=COCB1]),%=M%U,7VEIF!R(6THA2'UCZ>0L"V>.:V6X=%,'8R:(QX
M]*%=*S^WRCC'L,4?(XT8!"3F9/\:F?YW-Q1K\5KO?J8/UY#]"YSM:U:+/*RS
M?67@Z4Z/>L:#M,[Z/IST[SSJ\2D]\2@;U8)Q<#"L'<3R8V#<C5$"7NL$HMH'
MU_4&!_9V\E]Q'*@65I!RO]N&9-Z8V,4U2L\TP>AHO;M0=E&@Z^[VS3C5+N$,
M;,A:BD30;?D"*D.7_A,<#^$OIMXW56HZN[K(%9R;25T5F*:.UYM#=-,I;# E
M?P!,R>I<%EOD7HUJ)UW1*>E&E3=+/K.V(EY!"2)[77EAJD.D'928(RC[9L:U
M4RD2,Z)B,7>PN&9M%+")[0E,BE(6C&#0%;$.J^N-\79P/9;$GXMGS\L"[US9
MG5"Y7$ 52W@<?[+XAA@7H%2<%<"O(&J;6T=A@%7XRTO>1IR:O%'<U+XA]X+6
M>C_K*#7?XUG]'J.O_1H)^6[>HY&MQ]%Q@?P/$TY<>&S2+T#032_"LICJH6:#
MXY2/;#*\=_9W02N0P'.7BJ:>,F^"/#]3$R[>2U*"&-5EPH7T5$BE4O%=7&V[
M=PN/&%Q"]SQ7 9:0)1, ]DH>RZS@S+-0#S1,78YCAMG1@#++8II*VSEZ$AQ]
M[W?QU1A^43,8]Y8,#E4 .KD"D:Z(Y1SO@H8)7M> HFZ4I&W<Q143M%(?;)X*
MCPN>>["+!?WVP>YYYHW*&^IL388+>+ ?LNV(N#WUT(_PB,/KI@8>)29**+[.
MN0X2[!)>?&E7&"VF.O+>'F<Q"'F.$NY6F\_9P75/Q0DR3DT0/\4<! 6Q6#WL
MA/+J*U/AJ:D)(P,VQO94ION6"JV47#SRGGOAXC3TU,I'SJ.M4U+RP!;3$?P>
M%!71SB#D+&Q#Q]WNP'(M\L:55[L"$M924KA_3SBB;]WXVCO^7%?VV+9DC^48
MC/FX:+>Z9 N^GO:>G;R36IT$?+UE#%&'ED<0CE?\R\X-'$H.Y[6]58V*.9*Y
M@ A1\02H?A<5X1C*U5RH*_&KY,<@3H;S1?"%*]OW1FSH/M(2AZG'=!JMD<?&
MQ@=&A+7)'@0Y:,O@D7/XY!^6B3.FV?9V.^; 0;"BR[MXH-##AYI$G%Q#W#6\
M&KZZ29')I</I>>W3#2*QQ\8I$SP("$**'0E0'\68PZ&Q41,8PG7/FUK(=]RK
M94S%N UI7/YNS5T9]]JS0$[D2"%1O-)3?I@2A<EAP>VJ:W&V"Q8(^;[?-@[)
MM-.K7EX?!UN$341DCV;!A \/J=V8WRK#_CIZ6J!E,E3LOG3AF\C11-A-> QZ
M\SQ06YQ//"3$(QED9)&AR:[R%?&@<JW;6*/$T@VU@:HF^$VZ;X;A+YREB83!
M.BSN>F/#;0V:OP4_<YMN#1O0TP\"6>/-#T](B0M-".$=G&W98QB:M^PYUR#@
MZ-NE\BP+NBNV!<(9"Z5BWTUX I5PQRPX<LGP/S8>3$-$CS3*MV 1. "^NS9M
M7+O@;<\]-9B,J;1/(UUQ93FM;.#!OF;Q"V[WGN^XL\A#.B8]QCPI@U*^"9[L
MQO#O<)=I-U[LC'9ALQ8+)1QB-;,U8RA/7!6#4$-XO-R%^T3YY,2.(NP+515:
M5#9HT$D]-51MX3U)+? 0N1X1CXGJF[V:;XA]N/$@UD$_O-R@']KHAY<;],,&
M^K\RUO9R;>C_P<GQAZ/#P?'%T?['HXM_$Q_I)DKZ\$'B3$U[X!5E1D<NIM/3
M @'T75Y<9BJ=F(8&ZR6_Q-64@P[<<ZD)[9@YU[4Z:'>.!=-'27U%AKEZD^6G
M ?C5IGZPJDWTV6NBQBUH"':[MS$P[AU+63/3_L-Q#*YF%7I-[601NXJ,;^B$
MXY+N38O+&!:_5M2MDX@82\2G8\U5(FN-L0T,HX4,]K&S0J4W$:>GGYCL-#R<
MK%ML7PMCPDY'F:PQ@YK90K7+$U. 4,+$:'0FY0A]SVQ2E+"L,XH3$QA:TWB%
MF\R+,H.1/D7JA DM#L5OYC7%CNMI@:2,5=&4]$WY"\I"6O""\5P0ZH[!H+R*
M)5X)G@;=#-Q($(6*4$ZS)DL41;6Q<!!CV<H,H2@R^;J6E!@^Q)\F?AE6<"[T
M(TG>(!$LR7.,M8HC,,KI9[#+8$QDR<?LF3>8*#1/==!],/)X9L)?!0+#1,GX
M*U//%BQ;M$(:XVFQH[7"A<%HG^)UJZXJ<)II4D3"S@Q3#*TM,?6 (LSR75^Q
M.\MY.S\N*\$S\E(#T+V1#@&Y%[7L$^_O_GV$PS;EX!_M@TH"VS=.+^+>Y\TM
MW )8>8E[*-BP876XQ_[,?'6T@".,TTL9![V<O,CW)/)KX?Q!%R_G];FYL3.5
M,*>-*BF9O4!ST6':#0E8+Q6")[-F&1$29_Z(8F K30P#B%>%,O8*V;MNK:>$
M0O74U4*\[ZO8>X?H#C,RI3+0E,IA4W@T!I]2Q3U0<-DC$2?56_A[_$(RHEA^
M9 ^&&R&L;%L!:E.<3!J$D$UUIDC6\3:ML()[)0;N9!)%EF[-],\5()3?\!Q=
MW>TMSP<W_>1:T@&KGNC2UUA<^^=DAOG-DU1C0;'?Z8V\0I; 5N]ECV TH$%H
M';FN[_>R@]D5-?-!HSADVSE,#4=S]1F.2MZ&&#P"\2'_0* &WK'(20W8"%ER
M:3-)W3!6@:J8,@;K0LX"EDF#)!7B$<S(>-F$*UMBX&L#TG#6(&CMPG6TCJW"
M[FQ\3>IPJ-"4J.35^2^5);>0[!(G2WW4#;-3P?:P=%A]:P8SDSADWP!,0DP"
MS)(Z@M^]DGF&XWA4QO"24 M,FDS.LU_!YACIOI2?5(AB[!;-#L9;F%3>T.7V
MZ%X8F"S*29+KWWB44^J,& G!![XAOY*?0A?)I5],+D0!L21RI<XD:<6=6FT.
M3=SE)6(@.RPYG80\$8<+Z?0$IIC[042A(FV)B95628H)-L2EZ3!GMN0-V<:.
MI.AR0]Q/1["M(:8X$9EWU?H%BQT@4@E&',J4T4;WXDK=1S=NLF^=ENRUACT-
MN;W%V#24!GR+V$1=MPTJ:SN-T,C@$]BS^]#*F:'@FI::5N&'%IHEM^?/K6V;
M)G4"XP#S+I/?D/ "S^I1J<GF==:]9\7ZMK3L:&X9(0P8#/1*Z(E5,:XOT69R
M5J[]DUB;IH6;!'I!@KA-)]JT"9O!J0HL9F=)TJ9F -LLJ3[OT2<$AX)]RGB/
M B0R36*T-1,!?N2RE&T?P\@L#00])E=4&9C>DLB"73-LK'&..P0V9NK.^**D
M8X[R>[0$"=I7[&1Q25G)O["QB,D!VO^<S9$^H+0K*><MU^-ZS*]*/9DRMLMW
MR%"5L5DDY8YT96,@\]V'H,T(1B=<AOH%ICK/3*\2[A:4N;28+BE-,HOL@-#O
M\;T0IN&0;K+B.J'9'8L"J@4!1ZPI)BG"PNFW;(G[BS %.YID1:YH57X%GPM!
MI%QB24:] -_1! OQ[NC=X2E Y<D61^>@=0Y1QWD]0<\9<CW)WTF#>@O7P[1F
MX$(0)@;_;,L+X8\,DH$]IFS"HFW$@<:M(VKTU$YIO.14BZ]=>E6+52MP7J%5
M53$:I+7]KMFP,3;7T/(VQ?9F-]JXO,+;8M6'#\H*O7!3L5YUI+3BF;9(?]8L
M<C'M?B^)CYZ$3]R($NEQ>LP7D)7+G+(2,4@]"72%.?#>961CE+V3:EE'K74.
M0N<AE7V.E2OU9<9R@TL!)89L%2YKZ%(\X7(9]X,2J*Z6I-WYR)?-;W4:?MNS
M=YT,RJM-!J6=07FUR: \&!'NCU"W(+^@V='A)#\8;,4K.A67!E[6T%#+'/37
M5+"&$27L%N0I6=9 -\/'8C(9)JOAP,7C5(W1@;+.?%ZA)P\>$Q(T6 00,I6Q
M.0/Z#S8<NH#@X.;@HXXXM$6J#^-ER,F%AVO;P<'B?XZS,,0/GC*BI_B4C00-
MQ;+$P(2Z>?4%F8L41D>?+&9B!APG6W=8XF #>0U9Y4+ <?-'"40CW?6 5/@T
MS[)S9XP%A]SB05[:9-R4 A1>+IR"70U9-,E(Z])H+@T,^6<7YT<(B=3+9)5A
M;Y$U RD^D'I9.J@]GYOZO21T=$W_Y!Y[Z"MY#OD&A<.C"48MYD '/5<J0(@^
MAXIBR.RO;!D5QRJI=*>WV]Z*H-:?U!HXHF!_,<FU#X/$8VI24)B550^&=.!%
MW%%,YWK*L7OM4?%GRB"OP17<9>P;)^ ,@VF_<M#2,8G8_&Y6I4.ZJJF6;WYN
MGZTMZ,KBOX7S];J\<0>>^+BE*%&5K!I O+3BLJ<4U*J3GK!XX.PR50-^BVLQ
MD9T,SN&QEMYVE"CB/UQ7NNE<;%B8' \;)CPU*M["'"VYT5IGV <^NMIY]\]*
MS<UQC_&WI>^-W$VSP%1X0^308US/19--I*>5JT$QL>];O DN5"'6WJ9& '2'
M1EHBT<NZ6F*F&4/$+<[>KUNEO=%%7TL7_1YEQ"5>*+<!%MC+,52UFE<^*GGI
M'J H UO9-K-#I4\BK5XNP?9CGA8NRR>L#[GB> ;:7+*EPWVVD?^-_ ?R?\L-
MX*I!_+.M5+.""Z/G($DI6-19D:0F-)E7,RE1U&W);SD"7$:_RA/P"C\I:-MC
M.(H@]YR1';?#IX WDA_VWS U1NT0P%Q:VI'+N-D#?\@]L+C1%C@%>9VC9=%?
MA-'FZS$6%Q<'87_RI/90#K"5=K[;=7%LU]6]A]M]%7IBI#BIV-JA8'PUY6W
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M-2P4U/AEUF"I0NUQ5;8NCNRU$T0QYEQ?CW4U5]@9J40^>+OY?1(#&6# <D(
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M&(\?A6$5[4290%X8K8Q#7LR-T-Z?T*Y?-&VR(S\.]G$9//D5/0G.6,)B$G1
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M/S(R;D1\(^+?1L3W?65M#.MYD2'?/GR+68%)\]N2&]/9#:07VWQ3M5)2IE7
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MXT9*!&'FD!AT ONONS2*LJVMA$!P+:1[8N( @KH!PU@01ML*J$KPRPB% C1
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M,N="(=;H7]M>GO+-O.21,;6%HK]<RW.UR V.H %[,QF_1+I/$"_;L%\0EG=
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M=7:4Z,:DTEL?3)DE?$5:YY$-T-M"&-3<48(;$QMI^@+1,0OP]A/>%8E^ &V
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MCHW3W6K&*;R%QP*LM=H07U!P1QEECI5=ZARDUB(?,P7E=911IB?9U=9?(K;
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MBX)R#;"IE#[HCN-74<FG+7LX^+"[Q7,LS.*-.[Q5'W1##\63J]+BM?;JM%Z
MEF52[_>=@P[JYA_T=\EQ\\/\21E]Y/]02P,$%     @ .D&(6Q"7*NK["P
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M7H;J!:"Y?$:L+ )]DX4@58KM_>7U31?BD]BL-XF_YC@C8LO_ 5!+ P04
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MO[$_[-]%,$?^!5!+ 0(4 Q0    ( #I!B%M[150V01X  $NH   9
M      "  0    !E83 R-C@W.#DM.&M?:VEN9&QY;60N:'1M4$L! A0#%
M  @ .D&(6W8_SFU<10  N'H! !X              ( !>!X  &5A,#(V.#<X
M.3 Q97@Q,"TQ7VMI;F1L>6UD+FAT;5!+ 0(4 Q0    ( #I!B%N5-5O8^4(
M -1M 0 >              "  1!D  !E83 R-C@W.#DP,65X,3 M,E]K:6YD
M;'EM9"YH=&U02P$"% ,4    "  Z08A;^#*85943  #B0@  '@
M    @ %%IP  96$P,C8X-S@Y,#%E>#DY+3%?:VEN9&QY;60N:'1M4$L! A0#
M%     @ .D&(6R_][G+2 P  ! \  !(              ( !%KL  &YA:V%W
M+3(P,C4Q,C X+GAS9%!+ 0(4 Q0    ( #I!B%OYP'&: @D  ,YH   6
M          "  1B_  !N86MA=RTR,#(U,3(P.%]D968N>&UL4$L! A0#%
M  @ .D&(6Q"7*NK["P  HY   !8              ( !3L@  &YA:V%W+3(P
M,C4Q,C X7VQA8BYX;6Q02P$"% ,4    "  Z08A;3?>]@$X(  !H8P  %@
M            @ %]U   ;F%K87<M,C R-3$R,#A?<')E+GAM;%!+!08
."  ( #<"  #_W      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ea0268789-8k_kindlymd_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NAKAW="http://kindlymd.com/20251208"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nakaw-20251208.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001946573</identifier>
        </entity>
        <period>
            <startDate>2025-12-08</startDate>
            <endDate>2025-12-08</endDate>
        </period>
    </context>
    <context id="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001946573</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NAKAW:CommonStockParValue0.001Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-08</startDate>
            <endDate>2025-12-08</endDate>
        </period>
    </context>
    <context id="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001946573</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NAKAW:TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-08</startDate>
            <endDate>2025-12-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-12-08" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-08" id="Fact000004">0001946573</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-08" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-08" id="Fact000010">2025-12-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-08" id="Fact000011">Kindly MD, Inc.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2025-12-08" id="Fact000012">001-42103</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-08" id="Fact000013">84-3829824</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-08" id="Fact000014">5097 South 900 East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-12-08" id="Fact000015">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-08" id="Fact000016">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-08" id="Fact000017">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-08" id="Fact000018">84117</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-08" id="Fact000019">385</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-08" id="Fact000020">388-8220</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-08" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-08" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-08" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-08" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member"
      id="Fact000025">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member"
      id="Fact000026">NAKA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-082025-12-08_custom_CommonStockParValue0.001Member"
      id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember"
      id="Fact000028">Tradeable Warrants to purchase shares of Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-082025-12-08_custom_TradeableWarrantsToPurchaseSharesOfCommonStockParValue0.001PerShareMember"
      id="Fact000029">NAKAW</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-08" id="Fact000030">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-12-08" id="Fact000031">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
